{"study_id": 9846, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the physicochemical properties of Cordyceps militaris polysaccharides (CMFPs) under different drying methods and evaluate their effects on ulcerative colitis (UC) in zebrafish.", "results_summary": "CMFPs repaired the intestinal mucosal barrier, reduced oxidative stress markers (ROS, MDA, MPO), enhanced antioxidant enzymes (SOD, CAT, ACP, AKP, LZM), and improved UC via the MyD88/NF-\u03baB pathway, though drying methods influenced immune-related enzyme and cytokine regulation differently.", "population_specificity": "Oxazolone-induced zebrafish (animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:08.812326+00:00"}
{"study_id": 9851, "supplement_id": 1051, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and potential mechanisms of Cordyceps in treating arrhythmia, specifically bradycardia and tachycardia.", "results_summary": "Cordyceps significantly improved the total efficacy rate in both bradycardia and tachycardia patients, with no serious adverse events reported. Key mechanisms may involve adrenergic signaling in cardiomyocytes and the PI3K-Akt signaling pathway.", "population_specificity": "1,805 patients with arrhythmia (918 treated with Cordyceps plus routine drugs, 887 with routine drugs alone).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:09.539042+00:00"}
{"study_id": 9847, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the underlying mechanism of Bailing Capsule (containing Cordyceps sinensis) in attenuating diabetic nephropathy in rats.", "results_summary": "Bailing Capsule improved renal function, reduced kidney triglyceride accumulation, and modulated lipid metabolism pathways (PPAR\u03b1, ACOX1, SCD, FASN) in diabetic rats. It also alleviated glomerulosclerosis, tubulointerstitial injury, and renal fibrosis.", "population_specificity": "Diabetic rats with streptozotocin-induced nephropathy.", "effective_dosage": "Low and high doses (specific amounts not stated).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:09.836312+00:00"}
{"study_id": 9848, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of UV-C radiation on the virulence of Cordyceps fumosorosea against Plutella xylostella and its potential as a pest management tool.", "results_summary": "UV-C exposure before fungal application increased the mortality rate of P. xylostella, enhancing the virulence of C. fumosorosea. However, UV-C exposure after fungal treatment reduced virulence temporarily, with no effect on secondary infection.", "population_specificity": "Plutella xylostella (a destructive vegetable pest)", "effective_dosage": "Not specified", "study_duration": "Exposure times of 3, 6, 12, and 24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:09.967433+00:00"}
{"study_id": 9845, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to predict the potential mechanism of Cordyceps cicadae in treating renal ischemia/reperfusion injury (IRI) using network pharmacology.", "results_summary": "The study identified 81 shared target genes between Cordyceps cicadae's active ingredients and renal IRI, highlighting key genes (ALB, GAPDH, CASP3, MAPK1, FN1, IL-10) and signaling pathways (MAPK, cAMP, PPAR, Rap1, HIF-1) as potential therapeutic mechanisms.", "population_specificity": "Not specified (in silico analysis).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:10.238883+00:00"}
{"study_id": 9850, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the mechanism of action of Cordyceps sinensis in treating oral lichen planus (OLP) and provide theoretical support for improving OLP treatment regimens.", "results_summary": "The study identified 21 active compounds in Cordyceps sinensis targeting 67 OLP-related genes, including TNF, IL-6, CD4, EGFR, and IL1B, primarily involved in PI3K-Akt and MAPK signaling pathways, regulating apoptosis, T cell activation, and oxidative stress. Molecular docking confirmed binding between these targets and active components.", "population_specificity": "Not specified (in silico study, no human or animal subjects).", "effective_dosage": "Not available.", "study_duration": "Not applicable (computational analysis).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:11.063751+00:00"}
{"study_id": 9853, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to summarize the clinical usage and biological activities of Cordyceps sinensis, particularly its potential benefits in treating diabetic kidney disease (DKD).", "results_summary": "The study found that Cordyceps sinensis exhibits nephroprotective, anti-inflammatory, anti-oxidant, and anti-hyperglycemic effects, with several Chinese patent medicines derived from it showing considerable efficacy in treating DKD.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:16.228912+00:00"}
{"study_id": 9854, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the relationship between oxidative stress and beauvericin (BEA) synthesis in Cordyceps chanhua, focusing on its secondary metabolism under H2O2-induced stress.", "results_summary": "The study found that oxidative stress significantly increased BEA content (13-fold) and enriched genes and metabolites related to non-ribosomal peptide metabolism, suggesting BEA may play a role in oxidative stress resistance.", "population_specificity": "Cordyceps chanhua mycelia (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:17.144711+00:00"}
{"study_id": 9855, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify commercially available Cordyceps extracts containing myriocin and test their efficacy in improving metabolic outcomes in obese mice.", "results_summary": "The study found that Cordyceps extracts containing myriocin reduced ceramide levels, increased energy expenditure, prevented diet-induced obesity, improved glucose homeostasis, and resolved hepatic steatosis in obese mice. These effects were linked to enhanced adipose tissue browning, improved brown adipose tissue function, and gut microbiome alterations.", "population_specificity": "Obese mice", "effective_dosage": "Human equivalent dose (specific amount not detailed)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:17.244776+00:00"}
{"study_id": 9856, "supplement_id": 1051, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antileukaemic cell proliferation activities of golden cordyceps extracts and compare them with standard cordycepin in leukaemic cell lines.", "results_summary": "Golden cordyceps extracts showed cytotoxic effects on leukaemic cells, reduced WT1 protein expression, inhibited cell cycle progression, and slightly increased CD11b levels, confirming antileukaemic activity without affecting normal blood cells.", "population_specificity": "Leukaemic cell lines (EoL-1, U937, KG-1a).", "effective_dosage": "Highest IC50 value of 16.5 \u00b1 3.9 \u00b5g/mL (specific dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:18.467750+00:00"}
{"study_id": 9859, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the potential antidepressant mechanisms of Cordyceps sinensis using network pharmacology and molecular docking techniques.", "results_summary": "The study identified 7 active ingredients in Cordyceps sinensis and 41 common targets related to depression, suggesting antidepressant effects through modulation of key targets like CAT, CREBBP, EGF, and EP300, as well as signaling pathways such as foxo, HIF-1, and Huntington's disease. Molecular docking confirmed good binding between core targets and active ingredients.", "population_specificity": "Not specified (in silico study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:18.901712+00:00"}
{"study_id": 9858, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective effects of Cordyceps cicadae mycelium extract (CCME) in an optic nerve crush (ONC) model, focusing on antiapoptotic and anti-inflammatory actions.", "results_summary": "CCME treatment significantly increased retinal ganglion cell density and visual function while reducing apoptosis and inflammation in the optic nerve compared to the control group. The P1-N2 amplitude and RGC density improved by 5.15- and 3.13-fold, respectively, and TUNEL-positive and ED1-positive cells decreased by 4.38- and 6.63-fold.", "population_specificity": "Adult male Wistar rats (aged 7-8 weeks)", "effective_dosage": "100 mg/kg once daily", "study_duration": "7 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.798633+00:00"}
{"study_id": 9860, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of Cordyceps militaris mycelia on chronic kidney disease (CKD) in mice, using four different culture media.", "results_summary": "Cordyceps militaris mycelia cultured in HKS or CM + A medium significantly reduced blood urea nitrogen (BUN) and serum creatinine levels in mice with CKD, suggesting potential benefits for kidney function. The effects varied by medium type and time point, with HKS + A showing the most consistent reductions.", "population_specificity": "Mice with chronic kidney disease (CKD).", "effective_dosage": "Not specified.", "study_duration": "10 to 30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.914292+00:00"}
{"study_id": 9857, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antibacterial properties, antioxidant activity, and bioactive compounds (cordycepin, adenosine, flavonoids, phenolics) of Cordyceps militaris extracts from different samples in Thailand.", "results_summary": "The study found that Cordyceps militaris extracts exhibited antibacterial activity against multiple pathogens, including MRSA, with MIC/MBC ranging from 3.91 to 31.25 mg/mL. Ethanolic extracts showed rapid bacterial inhibition (2-4 h), high cordycepin and adenosine content, and significant antioxidant activity, with sample A demonstrating the highest flavonoid and phenolic content.", "population_specificity": "Not specified (in vitro study on bacterial strains).", "effective_dosage": "Extracts tested at concentrations of 2-4 mg/mL for gene expression and 3.91-31.25 mg/mL for antibacterial activity.", "study_duration": "Not specified (acute effects measured within hours).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:20.734349+00:00"}
{"study_id": 9861, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of cordycepin (COR) from Cordyceps militaris on aging-associated testicular inflammation and serum biochemical changes in naturally aged rats.", "results_summary": "COR treatment significantly improved altered biochemical parameters (blood cell count, lipid metabolism, liver function) and reduced inflammatory mediators (COX-2, IL-6, IL-1\u03b2, TNF-\u03b1) in aged rats, mediated by NF-\u03baB and MAPKs signaling pathways.", "population_specificity": "Male Sprague Dawley rats (young and aged groups)", "effective_dosage": "5, 10, and 20 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.288087+00:00"}
{"study_id": 9863, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether selenium peptides (Se-Ps) derived from Se-enriched Cordyceps militaris could provide neuroprotection by reducing neuroinflammation and oxidative stress, potentially aiding in the prevention or treatment of Alzheimer's disease.", "results_summary": "The study found that Se-Ps significantly increased cell viability, reduced inflammatory and oxidative stress markers, improved cognitive function in LPS-injured mice, and positively modulated gut microbiota by increasing beneficial bacteria and reducing harmful ones.", "population_specificity": "LPS-injured mice (animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:26.025451+00:00"}
{"study_id": 9862, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to enhance cordycepin production in Cordyceps militaris by modifying its epigenetic status using valproic acid (VPA).", "results_summary": "VPA supplementation at 50 micromolar increased cordycepin production by 41.187% via upregulation of key genes, achieving a maximum yield of 2,835.32 mg/L in small-scale cultures, though scaled-up production saw a slight decrease due to system limitations.", "population_specificity": "Cordyceps militaris (fungal culture)", "effective_dosage": "50 micromolar VPA", "study_duration": "At least 2 days post-VPA treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:26.091290+00:00"}
{"study_id": 9864, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the mechanism by which Cordyceps cicadae protects against hypertensive nephropathy, focusing on autophagy regulation and the SIRT1/FOXO3a pathway.", "results_summary": "Cordyceps cicadae reduced renal tubular epithelial cell damage, fibrosis-related protein expression, and autophagy stress, while also upregulating SIRT1/FOXO3a and reducing oxidative stress, similar to resveratrol.", "population_specificity": "Spontaneously hypertensive rats (SHRs) and NRK-52E cells exposed to AngII, with additional observations in hypertensive nephropathy patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:28.106901+00:00"}
{"study_id": 9865, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the functional and quality improvement of retorted Korean ginseng chicken soup hydrolyzed using Cordyceps militaris extract, alone or combined with bromelain or flavorzyme.", "results_summary": "The study found that Cordyceps militaris extract, especially when combined with bromelain (CMB), significantly improved antioxidant activity, water-holding capacity, and meat tenderness, while enhancing umami taste properties through increased 5'-nucleotides and free amino acids.", "population_specificity": "Commercial broiler chicken breast meat (36 samples).", "effective_dosage": "Not specified (extract used in hydrolysis at 55\u00b0C for 2.5 h).", "study_duration": "2.5 hours of hydrolysis followed by 1-hour retorting.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:28.914514+00:00"}
{"study_id": 9867, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of salt treatments on Cordyceps militaris growth and cordycepin production, as well as identify genes involved in the biosynthesis pathway.", "results_summary": "Salt treatments inhibited C. militaris growth but significantly increased cordycepin production, with a 7% salt-treated group showing a five-fold increase compared to the control. Transcriptome analysis revealed differentially expressed genes linked to cordycepin biosynthesis.", "population_specificity": "In vitro study on Cordyceps militaris cultures.", "effective_dosage": "Not specified (salt concentrations tested, including 7%).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:29.375704+00:00"}
{"study_id": 9866, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the caspase-3-dependent programmed cell death mechanisms (apoptosis and pyroptosis) of Cordyceps militaris extract (CME) in A549 lung cancer cells and validate its anticancer properties.", "results_summary": "CME induced pyroptosis and apoptosis in A549 cells, inhibited cell proliferation, and upregulated caspase-3-dependent pathways (GSDME and PARP). High concentrations (200 \u03bcg/ml) caused cell cycle arrest and suppressed proliferative proteins, while lower concentrations (1-100 \u03bcg/ml) had minimal effects.", "population_specificity": "A549 lung cancer cells (in vitro study).", "effective_dosage": "1-200 \u03bcg/ml of CME.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:29.966032+00:00"}
{"study_id": 55093, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy and mechanism of action of Bailing capsules (derived from Cordyceps) in treating COPD using meta-analysis and network pharmacology.", "results_summary": "The meta-analysis of 27 RCTs showed significant improvements in lung function (FEV1, FEV1/FVC), exercise tolerance (6MWT), reduced acute COPD attacks, and improved quality of life. Network pharmacology identified SRC, HIF1A, NFKB1, HDAC2, and PRKACA as potential core targets for Bailing capsules in COPD treatment.", "population_specificity": "Patients with stable COPD.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:29.978678+00:00"}
{"study_id": 55098, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to review the chemical composition, pharmacological actions, and mechanisms of Cordyceps and Ophiocordyceps spp. mycelium in treating atherosclerosis.", "results_summary": "The study found that Cordyceps exhibits anti-atherosclerotic effects through anti-inflammatory, antioxidant, cholesterol-lowering, platelet aggregation inhibition, and modulation of apoptosis or autophagy in vascular endothelial cells. However, misuse of terminology (Cordyceps vs. Ophiocordyceps sinensis) has complicated research.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:34.878589+00:00"}
{"study_id": 55094, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms and potential of cordycepin from Cordyceps militaris as an anticancer agent, including its effects on tumor cell proliferation, apoptosis, angiogenesis, metastasis, and immunomodulation.", "results_summary": "The study found that cordycepin inhibits tumor cell proliferation, induces apoptosis, suppresses angiogenesis and metastasis, and exhibits immunomodulatory effects in cancer treatment. It also discussed the current status, challenges, and future prospects of cordycepin in clinical trials.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.179309+00:00"}
{"study_id": 55097, "supplement_id": 1051, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the immunostimulant effects and safety of a functional beverage derived from Cordyceps militaris (FCM) in healthy volunteers.", "results_summary": "The study found that FCM increased NK cell activity in both genders and reduced IL-1\u03b2 levels in men and IL-6 levels in women, with no significant differences in safety indices between the FCM and placebo groups.", "population_specificity": "Healthy men and women in Phayao Province, Thailand (n=10 per gender).", "effective_dosage": "2.85 mg of cordycepin (FCM) daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.217309+00:00"}
{"study_id": 55107, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of medicinal fungi, including Cordyceps, as sources of new antiviral compounds.", "results_summary": "The abstract does not provide specific findings about Cordyceps's effects.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:36.188801+00:00"}
{"study_id": 55100, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to survey medicinal plants, including Cordyceps, used in traditional Chinese medicine for their potential anti-HIV properties.", "results_summary": "The abstract mentions Cordyceps as one of the medicinal plants with anti-HIV properties, but specific efficacy data or mechanisms for Cordyceps are not detailed. The study compiles evidence from various sources but does not provide direct experimental results for Cordyceps.", "population_specificity": "Not specified (general review of literature)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:36.255003+00:00"}
{"study_id": 55104, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the antineoplastic activity of edible/medicinal mushrooms, including Cordyceps, against breast cancer cells, focusing on bioactive compounds and their mechanisms of action.", "results_summary": "The study found that edible/medicinal mushrooms, including Cordyceps, exhibit in vitro and in vivo anticancer effects on various tumors, particularly breast cancer, through multiple pharmacological activities such as antibacterial, anti-inflammatory, and immunomodulating properties.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:37.751478+00:00"}
{"study_id": 55105, "supplement_id": 1051, "safety_score": "75", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical effects of mushroom supplements, including Cordyceps, in cancer care over the past decade.", "results_summary": "The study found that mushroom supplements, including Cordyceps, showed potential benefits such as improved quality of life, reduced symptom burden, and favorable immunological responses, though evidence remains inconclusive for routine use. Some studies reported survival benefits with specific mushroom preparations, but most had small sample sizes and lacked rigorous designs.", "population_specificity": "Cancer patients receiving conventional treatments.", "effective_dosage": "Not specified for Cordyceps.", "study_duration": "Not specified for Cordyceps.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:38.508634+00:00"}
{"study_id": 55101, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of cordycepin, derived from Cordyceps, in treating hematological malignancies by examining its mechanisms of action and effects.", "results_summary": "Cordycepin demonstrated anti-tumor, anti-inflammatory, and anti-metastatic activities, inducing apoptosis in various hematological malignancy subtypes by targeting adenosine receptors, death receptors, and key signaling pathways like MAPK, ERK, PI3K, AKT, and GSK-3\u03b2/\u03b2-catenin. Evidence from in vitro, in vivo, and clinical trials supports its potential as a promising cancer treatment.", "population_specificity": "Hematological malignancy patients (specific subtypes not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:38.906603+00:00"}
{"study_id": 55112, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore integrative medicine strategies, including Cordyceps, for supporting recovery from mild-to-moderate COVID-19.", "results_summary": "The abstract suggests Cordyceps has potential utility in supporting recovery from COVID-19, based on clinically studied effects in related conditions, but no specific results are provided.", "population_specificity": "Individuals recovering from mild-to-moderate COVID-19.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:42.651272+00:00"}
{"study_id": 55116, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of Cordyceps sinensis in regulating autophagy and its potential therapeutic effects on cardiovascular diseases.", "results_summary": "The abstract suggests that Cordyceps sinensis may influence autophagy, potentially protecting cardiomyocytes and vascular endothelial cells, but excessive autophagy could be harmful. The study highlights its potential as a future treatment strategy for cardiovascular diseases.", "population_specificity": "Not specified (general cardiovascular disease context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:43.509025+00:00"}
{"study_id": 55113, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to provide an overview of the current status of Chinese herbal formulations, including Cordyceps, as an add-on therapy for sepsis management.", "results_summary": "The abstract does not provide specific findings about Cordyceps's effects, only mentioning the general application of TCM in sepsis management.", "population_specificity": "Critically ill patients with sepsis or COVID-19 in ICU settings.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:43.527374+00:00"}
{"study_id": 55109, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the potential of natural products, including Cordyceps, in mitigating chemobrain-related cognitive impairments.", "results_summary": "The abstract does not provide specific findings about Cordyceps, only mentioning it as one of the natural products under review for potential benefits in chemobrain mitigation.", "population_specificity": "Not specified (general focus on cancer survivors with chemobrain).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.122140+00:00"}
{"study_id": 55111, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate cordycepin's anti-neuroinflammatory properties and its potential therapeutic effects in Alzheimer's disease, Parkinson's disease, and depression.", "results_summary": "The study highlights cordycepin's multiple beneficial actions, including anti-inflammatory, antidepressant, anti-Alzheimer's, and anti-Parkinsonian effects, as well as promotion of remyelination, by targeting neuroinflammatory pathways.", "population_specificity": "Not specified (review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.320499+00:00"}
{"study_id": 55117, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review synthesis methods for cordycepin, a major active compound in Cordyceps, and explore potential future strategies for its production.", "results_summary": "The abstract highlights cordycepin's diverse biological activities, including anti-tumor, immunomodulation, antioxidant, and anti-aging effects, but notes current synthesis methods have limitations in meeting demand. Future strategies may involve genetic engineering or synthetic biology approaches.", "population_specificity": "Not specified (review paper, not a clinical study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:45.888395+00:00"}
{"study_id": 55119, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers reviewed mushrooms, including Cordyceps, for their anti-breast cancer activity and mechanisms of anticancer action.", "results_summary": "The abstract mentions that Cordyceps sinensis has demonstrated antineoplastic effectiveness in human clinical trials, but specific results or mechanisms are not detailed.", "population_specificity": "Human clinical trials (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:46.390400+00:00"}
{"study_id": 55120, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "To evaluate the efficacy and safety of Cordyceps sinensis or its fermented products as an adjunctive treatment for patients undergoing maintenance hemodialysis.", "results_summary": "Cordyceps plus conventional treatment improved several biomarkers (C-reactive protein, serum albumin, malondialdehyde, hemoglobin) but did not significantly affect serum creatinine or LDL cholesterol. Adverse events were poorly documented.", "population_specificity": "Patients undergoing maintenance hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:49.820864+00:00"}
{"study_id": 55123, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cordyceps supplementation (20 mg/kg/day) enhances endurance training-induced adaptations in body composition, blood lipid profile, and oxidative stress in young sedentary individuals.", "results_summary": "The study found that Cordyceps supplementation slightly improved body composition but did not significantly alter blood lipid profiles or systemic oxidative stress after 8 weeks of endurance training.", "population_specificity": "Young sedentary adults (8 males, 6 females).", "effective_dosage": "20 mg/kg/day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:51.550492+00:00"}
{"study_id": 55121, "supplement_id": 1051, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential of computer-aided drug design techniques to accelerate the discovery of Cordyceps-derived medicines for treating various diseases.", "results_summary": "The study highlights Cordyceps' significant biological activities and its potential for treating diseases like diabetes, cancers, and neurological disorders with minimal side effects. It emphasizes the role of computer-aided drug design in improving drug discovery efficiency.", "population_specificity": "Not specified (general focus on potential clinical applications).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.369918+00:00"}
{"study_id": 55127, "supplement_id": 1051, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the pharmacological actions, medical applications, and mechanisms of Fuzheng Huayu formula (FZHY), which includes Cordyceps, for treating chronic liver diseases.", "results_summary": "FZHY, containing Cordyceps, demonstrated antifibrotic effects by targeting multiple molecules and showed no serious adverse reactions. The review provided updates on recent advances in its medical applications and mechanisms.", "population_specificity": "Patients with chronic liver diseases (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.507601+00:00"}
{"study_id": 55122, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential efficacy and underlying mechanisms of Cordyceps and its bioactive ingredients in treating metabolic syndrome and associated comorbidities.", "results_summary": "The study found that Cordyceps exhibits multiple beneficial activities, including anti-inflammatory, immunoregulatory, hypoglycemic, renoprotective, and cardiovascular-protective effects, suggesting its potential as a therapeutic agent for metabolic-related disorders.", "population_specificity": "Not specified (general review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.713897+00:00"}
{"study_id": 55124, "supplement_id": 1051, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the anti-fatigue mechanisms, bioactive components, and clinical trials of natural medicines, including Cordyceps militaris, as potential treatments for sub-health and unexplained fatigue.", "results_summary": "The abstract suggests that Cordyceps militaris has specific anti-fatigue effects with small toxic and side effects, along with rich pharmacological activities, making it a promising treatment for sub-health conditions. However, detailed clinical trial results or statistical significance are not provided.", "population_specificity": "Not specified (general sub-health population and those with unexplained fatigue).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:53.128405+00:00"}
{"study_id": 55128, "supplement_id": 1051, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to confirm the immune-enhancing efficacy and evaluate the safety of Cordyceps mycelium culture extract (CBG-CS-2) in healthy adults.", "results_summary": "The CBG-CS-2 group showed a significant 38.8% enhancement in NK cell cytotoxic activity compared to the placebo group after 8 weeks, suggesting improved immune function with minimal inflammation. The study concluded that CBG-CS-2 is safe and effective for enhancing cell-mediated immunity.", "population_specificity": "Healthy adults", "effective_dosage": "1.68 g/day in capsules", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:55.551393+00:00"}
{"study_id": 55129, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the anti-tumor activity of CMPS-II (from fermented mycelium) and CBPS-II (from cultivated fruiting bodies) of Cordyceps militaris against H1299 lung cancer cells.", "results_summary": "CMPS-II showed a higher inhibition rate (54.55%) on H1299 tumor cells compared to CBPS-II (34.80%) at 500 \u03bcg/mL. Both polysaccharides increased apoptosis factors (Caspase-3, Caspase-9, p53) and reduced PCNA expression, with CMPS-II demonstrating stronger effects.", "population_specificity": "H1299 lung cancer cells (in vitro study).", "effective_dosage": "500 \u03bcg/mL.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:57.074421+00:00"}
{"study_id": 55132, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The study aimed to assess dietary knowledge, behavior, and nutritional status in Chinese malignancy inpatients, including the use of supplements like Cordyceps, but did not specifically evaluate its safety or efficacy.", "results_summary": "The study found that over 90% of participants consumed Cordyceps among other supplements, but no specific effects or outcomes related to Cordyceps were reported.", "population_specificity": "Chinese malignancy inpatients from 18 hospitals (n=535).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:59.341805+00:00"}
{"study_id": 55135, "supplement_id": 1051, "safety_score": "75", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Cordyceps exhibits glucocorticoid activity and its potential clinical implications.", "results_summary": "The study found that Cordyceps has some in vitro glucocorticoid activities, but clinical data to corroborate these findings is lacking. No significant adverse effects or safety concerns were reported.", "population_specificity": "Not specified (general assessment of preclinical and clinical data).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:00.107469+00:00"}
{"study_id": 55133, "supplement_id": 1051, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of a commercially available supplement containing Ophiocordyceps sinensis and Ganoderma lucidum on cognitive function in young, healthy human participants.", "results_summary": "The study found no significant differences in cognitive function domains (e.g., memory, executive function, attention) between the high-dose, low-dose, and placebo groups after 30 days of supplementation. The results indicate that the supplement did not enhance cognitive function in young, healthy participants.", "population_specificity": "Young, healthy physical education students (n = 96; 53 men, 43 women; mean age 26.3 \u00b1 3.21 years).", "effective_dosage": "High-dose and low-dose supplement groups (specific amounts not detailed in the abstract).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:02.134176+00:00"}
{"study_id": 55134, "supplement_id": 1051, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate cases of apparent Cordyceps poisoning in Southern Vietnam and identify the toxic components in the fungus.", "results_summary": "The study documented 60 cases of toxicity from Cordyceps-infected cicada flowers, with symptoms including dizziness, vomiting, seizures, and one fatality. The fungus was identified as Ophiocordyceps heteropoda, containing ibotenic acid but no musimol or muscarine.", "population_specificity": "Patients admitted to seven hospitals in Southern Vietnam after ingesting cicada flowers (2008\u20132015).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:02.431696+00:00"}
{"study_id": 55137, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effects of Cordyceps Capsules as part of symptomatic treatment for collagen type III glomerulopathy in a patient with proteinuria.", "results_summary": "The patient treated with Cordyceps Capsules (0.5 g/day) alongside benazepril showed resolution of proteinuria (~0.5 g/24-hour urine). The study suggests potential efficacy but lacks controls or statistical analysis.", "population_specificity": "A 24-year-old female with collagen type III glomerulopathy and proteinuria.", "effective_dosage": "0.5 g per day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:03.916833+00:00"}
{"study_id": 55138, "supplement_id": 1051, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Cordyceps sinensis, combined with Ganoderma lucidum, for treating hyperglycaemia and cardiovascular risk factors in individuals with metabolic syndrome and type 2 diabetes.", "results_summary": "The study found no significant effect of Cordyceps sinensis combined with Ganoderma lucidum on primary (blood glucose) or secondary outcome measures over 16 weeks, with no increased risk of adverse events.", "population_specificity": "84 participants with type 2 diabetes mellitus and metabolic syndrome.", "effective_dosage": "3 g/day of Ganoderma lucidum, with or without Cordyceps sinensis.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:05.950834+00:00"}
{"study_id": 55139, "supplement_id": 1051, "safety_score": "75", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the benefits and potential adverse effects of Cordyceps as an adjuvant immunosuppressive treatment for kidney transplant recipients.", "results_summary": "Cordyceps showed no significant difference in graft or patient survival compared to AZA but improved graft function and may reduce acute rejection episodes. Compared to low-dose CsA versus standard-dose CsA, Cordyceps did not demonstrate significant differences in patient survival, graft loss, or acute rejection, but there was limited evidence suggesting benefits in pulmonary infection and other biochemical markers.", "population_specificity": "Kidney transplant recipients", "effective_dosage": "Not specified", "study_duration": "Three months to one year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:08.392875+00:00"}
{"study_id": 55140, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Cordyceps (DCXC) could protect against contrast-induced nephropathy (CIN) in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography.", "results_summary": "Cordyceps treatment reduced the prevalence of CIN and the proportion of patients with a significant eGFR decrease, with intensive therapy showing greater effectiveness. Urine biomarkers of kidney injury (KIM-1, NGAL, IL-18) were also lower in the intensive therapy group.", "population_specificity": "Patients with type 2 diabetes and renal insufficiency (eGFR \u226460 mL/min/1.73 m\u00b2) undergoing coronary angiography.", "effective_dosage": "Standard therapy (2-g corbrin capsules, 3 times/day) and intensive therapy (3-g corbrin capsules, 3 times/day).", "study_duration": "3 days before and 3 days after angiography (total 6 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:10.582240+00:00"}
{"study_id": 55136, "supplement_id": 1051, "safety_score": "65", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy and safety of natural and fermented cordyceps preparations as adjuvant immunosuppressive therapy in kidney transplant patients.", "results_summary": "Cordyceps showed comparable acute rejection rates and survival outcomes to azathioprine-based therapy, with better kidney function and fewer metabolic complications. Combining cordyceps with cyclosporine A reduced treatment-induced nephrotoxicity compared to cyclosporine A monotherapy.", "population_specificity": "Kidney transplant patients", "effective_dosage": "Not specified", "study_duration": "6-12 months", "interactions": "Used with immunosuppressants (azathioprine, cyclosporine A)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:11.314795+00:00"}
{"study_id": 55141, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent progress in understanding cancer metastasis and evaluate the potential of natural products, including Cordyceps militaris, in targeting key pathways involved in cancer spread.", "results_summary": "The study identified Cordyceps militaris as one of several natural products that may disrupt key signaling pathways (e.g., PI3K/AKT, TGF-\u03b2) and suppress MMP-9 activity, potentially aiding in the management of cancer metastasis. These strategies were highlighted as low-toxicity approaches with holistic effects against cancer hallmarks.", "population_specificity": "Not specified (general cancer research context).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:11.677642+00:00"}
{"study_id": 55143, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the therapeutic effects and potential adverse effects of Cordyceps sinensis for treating chronic kidney disease (CKD).", "results_summary": "Cordyceps preparations significantly decreased serum creatinine, increased creatinine clearance, and reduced 24-hour proteinuria in CKD patients not on dialysis, though the evidence quality was low due to methodological flaws.", "population_specificity": "People with chronic kidney disease (CKD) not receiving dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:11.858582+00:00"}
{"study_id": 55142, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review existing evidence on the effectiveness of Ophiocordyceps sinensis (Cordyceps) for treating diabetic kidney disease (DKD).", "results_summary": "The meta-analysis found that Cordyceps combined with ACEI/ARB improved proteinuria, inflammation, and dyslipidemia in DKD patients but showed no effect on hyperglycemia. The study noted significant heterogeneity and low-quality trials, calling for further high-quality RCTs.", "population_specificity": "DKD stage III-IV patients (4,288 participants across 60 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Combined with ACEI/ARB (no other interactions mentioned).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:11.951034+00:00"}
{"study_id": 55131, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compile and review existing literature on the ethno-medicinal, phytochemical, and pharmacological properties of Cordyceps species, focusing on their bioactive compounds and potential therapeutic applications.", "results_summary": "The review identified 35 Cordyceps species with medicinal properties, highlighting over 200 bioactive metabolites, including nucleosides, sterols, and polysaccharides, which exhibit diverse pharmacological activities such as immunomodulatory, antioxidant, antitumor, and anti-inflammatory effects. Cordyceps sinensis was noted as the most extensively studied species, with cyclodepsipeptides, nucleosides, and polysaccharides being the most researched compounds.", "population_specificity": "Not specified (literature review encompassing in vitro and in vivo studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:12.203406+00:00"}
{"study_id": 55144, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the anti-fibrosis effects of Cordyceps sinensis in animal experiments and primary clinical trials.", "results_summary": "Cordyceps sinensis demonstrated some anti-fibrosis effects in animal experiments and preliminary clinical trials, suggesting potential benefits for liver fibrosis treatment.", "population_specificity": "Animal models and primary clinical trial participants (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:13.337023+00:00"}
{"study_id": 55146, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review recent advances in the biotechnological production of bioactive constituents from Cordyceps militaris and explore its novel applications.", "results_summary": "The abstract highlights Cordyceps militaris's significance in clinical and biotechnological applications, its genetic and biochemical properties, and recent advances in bioactive composition production. However, specific efficacy outcomes are not detailed.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:18.513450+00:00"}
{"study_id": 55145, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Rhodiola crenulata and Cordyceps sinensis supplementation during high-altitude training could enhance aerobic endurance capacity and physiological adaptations.", "results_summary": "The study found that the RC supplement group showed significantly longer exhaustive run time (+5.7% vs. +2.2%) and better preservation of parasympathetic activity (-41% vs. -51%) compared to placebo. Hematological improvements were similar in both groups, but erythropoietin levels remained higher in the placebo group.", "population_specificity": "18 male subjects undergoing high-altitude training at 2200 m.", "effective_dosage": "600 mg Cordyceps sinensis per day (combined with 1400 mg Rhodiola crenulata).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:18.631939+00:00"}
{"study_id": 55149, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the molecular mechanisms of cordycepin, an active ingredient in Cordyceps militaris, and its potential as an anti-cancer therapeutic.", "results_summary": "The study highlights cordycepin's significant therapeutic potential due to its interactions with nucleic acids, apoptosis, and cell cycle pathways, suggesting its utility in developing novel cancer treatments with reduced toxicity.", "population_specificity": "Not specified (review of molecular mechanisms, not a clinical trial).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:20.444825+00:00"}
{"study_id": 55147, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of Cordyceps sinensis, in combination with other Chinese herbal medicines and routine pharmacotherapy, on objective outcome measures (BODE index and 6MWT/D) in individuals with stable COPD.", "results_summary": "The study found that Cordyceps sinensis, when used in combination with other herbs and routine pharmacotherapy, showed relative benefits for BODE Index and 6MWT/D, with clinically meaningful improvements in multiple studies. However, these effects need cautious interpretation due to methodological weaknesses and variations in herbal formulations.", "population_specificity": "Individuals with stable chronic obstructive pulmonary disease (COPD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:20.633224+00:00"}
{"study_id": 55151, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether cordycepin-induced cell death in breast cancer cells was associated with estrogen receptor mechanisms.", "results_summary": "Cordycepin inhibited cell growth and reduced viability in both MDA-MB-231 and MCF-7 breast cancer cells, inducing apoptosis in the former and autophagy-associated cell death in the latter. The study identified mitochondrial translocation of Bax, cytochrome c release, and caspase activation as key mechanisms in MDA-MB-231 cells, while MCF-7 cells exhibited autophagic features.", "population_specificity": "Human breast cancer cell lines (MDA-MB-231 and MCF-7).", "effective_dosage": "Not specified (dose-responsive effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:21.891922+00:00"}
{"study_id": 55148, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Cordyceps sinensis C4 in combination with sertraline for treating premature ejaculation (PE) and assess the PEDT as a measure of treatment response.", "results_summary": "The study found that Cordyceps sinensis C4 combined with sertraline improved intravaginal ejaculatory latency time (IELT) and PEDT scores, with higher doses (100 mg sertraline) showing greater efficacy after extended treatment. Both regimens were well tolerated, with no significant difference in relapse rates.", "population_specificity": "218 male patients with premature ejaculation (PE).", "effective_dosage": "Mycelium of Cordyceps sinensis C4 (specific dosage not mentioned) and sertraline 50 mg daily, with some patients later increasing to 100 mg daily.", "study_duration": "Initial 8-week treatment, with an optional additional 4-week period for some patients.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:22.915188+00:00"}
{"study_id": 55150, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To study the preventative effects of Cordyceps on contrast-induced nephropathy (CIN) in patients with stable angina pectoris (SAP).", "results_summary": "Cordyceps treatment resulted in a lower prevalence of CIN (5.77% vs. 11.76%) compared to basic treatment, though the difference was not statistically significant. However, post-procedure markers of kidney injury (Scr, KIM-1, NGAL, IL18) were significantly lower in the Cordyceps group.", "population_specificity": "Patients with stable angina pectoris undergoing coronary angiography or intervention.", "effective_dosage": "3 g corbrin capsules, three times daily.", "study_duration": "3 days before and 3 days after angioplasty (6 days total).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:23.001982+00:00"}
{"study_id": 55152, "supplement_id": 1051, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Cordyceps sinensis (CS) could be used in combination with a low dose of cyclosporin A (CsA) for long-term treatment of kidney transplant patients to reduce complications and CsA dosage.", "results_summary": "The study found that while renal function and survival rates were similar between groups, the treatment group had significantly fewer complications and required lower CsA doses. Additionally, the treatment group showed higher serum IL-10 levels, suggesting potential immunomodulatory effects.", "population_specificity": "Kidney allograft recipients", "effective_dosage": "Not specified", "study_duration": "Long-term (exact duration not specified)", "interactions": "Reduced cyclosporin A (CsA) dosage required when used with Cordyceps sinensis", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:23.053285+00:00"}
{"study_id": 186062, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to determine whether supplementation with MIPS (potentially including Cordyceps) improved aspects of weekly training performance in active college-aged men.", "results_summary": "Both groups improved, but MIPS supplementation for 14 days did not significantly enhance performance compared to the control group.", "population_specificity": "Active college-aged men", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:29.222722+00:00"}
{"study_id": 186060, "supplement_id": 1051, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review the nutritional, pharmacological, and economic benefits of Cordyceps, focusing on four key species.", "results_summary": "The study highlights Cordyceps' nutritional value, pharmacological properties, and economic benefits, emphasizing its use in medicine, supplements, and cosmetics without reported side effects.", "population_specificity": "Not specified (general review, not a clinical study).", "effective_dosage": "Not mentioned.", "study_duration": "Not applicable (review study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:29.364525+00:00"}
{"study_id": 10553, "supplement_id": 1052, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the anti-aging potential of Cosmos caudatus extracts and fractions, focusing on their inhibition of collagenase, MMP-1, and MMP-3 activities in human dermal fibroblasts.", "results_summary": "The study found that CC-E2 and CC-E3 fractions inhibited collagenase activity, reduced MMP-1 and MMP-3 expression, and suppressed NF-\u03baB activation, with quercitrin and quercetin identified as major bioactive compounds. These effects suggest potential anti-aging benefits via collagen protection and MMP inhibition.", "population_specificity": "Human dermal fibroblasts (CCD-966SK cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:29.899050+00:00"}
{"study_id": 10556, "supplement_id": 1052, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Cosmos caudatus on bone metabolism biomarkers in ovariectomized rats as a model for postmenopausal osteoporosis.", "results_summary": "Cosmos caudatus supplementation prevented the increase in bone resorption markers (IL-1 and pyridinoline) in ovariectomized rats, showing comparable efficacy to calcium 1% supplementation.", "population_specificity": "Ovariectomized Sprague-Dawley rats (3 months old).", "effective_dosage": "100mg/kg, 200mg/kg, or 300mg/kg, 6 days per week.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:31.643558+00:00"}
{"study_id": 10557, "supplement_id": 1052, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of Cosmos caudatus as an alternative treatment for osteoporosis in post-menopausal conditions by evaluating bone histomorphometry parameters.", "results_summary": "Cosmos caudatus improved bone formation markers such as double-labeled surface, mineral appositional rate, osteoid volume, and osteoblast surface, outperforming calcium 1% in osteoid volume. The study suggests it may help restore bone damage in post-menopausal women.", "population_specificity": "Female Wistar rats (ovariectomized to model post-menopausal osteoporosis).", "effective_dosage": "500 mg/kg, force-fed six days a week.", "study_duration": "Eight weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:31.665841+00:00"}
{"study_id": 186063, "supplement_id": 1051, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy elderly subjects.", "results_summary": "After 12 weeks of Cs-4 supplementation, metabolic threshold increased by 10.5% and ventilatory threshold by 8.5%, with no significant changes in the placebo group or in Vo(2) max for either group. The study suggests Cs-4 improves exercise performance in healthy older subjects.", "population_specificity": "Healthy elderly subjects aged 50-75 years.", "effective_dosage": "333 mg capsules taken 3 times a day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:33.132882+00:00"}
{"study_id": 10555, "supplement_id": 1052, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of 12 weeks of Cosmos caudatus supplementation on cognitive function, mood status, blood biochemical profiles, and biomarkers in older adults with mild cognitive impairment (MCI).", "results_summary": "The study found that 12 weeks of Cosmos caudatus supplementation significantly improved global cognition (MMSE), reduced tension and total mood disturbance, and lowered oxidative stress (MDA levels) in older adults with MCI.", "population_specificity": "Older adults with mild cognitive impairment (MCI)", "effective_dosage": "250 mg of Cosmos caudatus per capsule, taken twice daily (total 500 mg/day)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:33.321956+00:00"}
{"study_id": 10554, "supplement_id": 1052, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To investigate the effects of Cosmos caudatus (CC) supplementation on brain activity using fMRI among older adults with mild cognitive impairment (MCI).", "results_summary": "CC supplementation significantly improved digit span scores and increased activation in the right DLPFC during a 1-back task and left DLPFC during the Stroop Color Word Test (congruent) task after 12 weeks. These findings suggest CC may enhance working memory in older adults with MCI.", "population_specificity": "Twenty older adults (60-75 years old) with mild cognitive impairment, 70% female.", "effective_dosage": "Two 500 mg capsules daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:33.552233+00:00"}
{"study_id": 55155, "supplement_id": 1052, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness and safety of Cosmos caudatus in treating type 2 diabetes using a metabolomic approach.", "results_summary": "The abstract does not provide specific results, as the study appears to be in progress or not yet concluded.", "population_specificity": "100 patients diagnosed with type 2 diabetes in a tertiary hospital in Malaysia.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:36.554542+00:00"}
{"study_id": 9668, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of FDA-approved antivirals (baloxavir vs. oseltamivir) in treating A(H5N1) influenza virus exposure through contaminated cow's milk in mice.", "results_summary": "The study found that baloxavir treatment improved disease outcomes (survival and reduced viral dissemination) compared to oseltamivir in mice lethally challenged with A(H5N1)-contaminated cow milk.", "population_specificity": "Mice (animal model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:37.379082+00:00"}
{"study_id": 9669, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the prevalence of cow's milk protein allergy (CMPA) in Bahrain and compare clinical characteristics between IgE-mediated and non-IgE-mediated CMPA.", "results_summary": "The study found a 2% prevalence of CMPA, with non-IgE-mediated cases being more common (77.3%). IgE-mediated CMPA presented with more severe symptoms, longer follow-up durations, and higher associations with other diseases compared to non-IgE-mediated CMPA.", "population_specificity": "Children diagnosed with CMPA at a pediatric gastroenterology outpatient clinic in Bahrain (2014-2022).", "effective_dosage": "Not specified", "study_duration": "Follow-up duration varied (IgE-mediated: 17.3 months \u00b1 14.0; non-IgE-mediated: 13.5 months \u00b1 13.4).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:40.401552+00:00"}
{"study_id": 9671, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the opinions of Mexican paediatricians with ESPGHAN guidelines on the diagnosis and management of Cow's Milk Allergy (CMA).", "results_summary": "The study found significant discrepancies between Mexican paediatricians and ESPGHAN guidelines, particularly regarding the role of vitamin D in preventing CMA, with Mexican paediatricians rejecting 19 out of 73 statements.", "population_specificity": "42 Mexican paediatricians and European paediatric gastroenterologists.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:40.608185+00:00"}
{"study_id": 9674, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze global pediatric CMPA research trends and identify future directions for understanding and treating cow's milk protein allergy.", "results_summary": "The study found increasing annual publications on pediatric CMPA, with significant contributions from the Icahn School of Medicine. Current research emphasizes personalized therapy, probiotics, and gut microbiota, with future focus on microbiota-related treatments.", "population_specificity": "Children with cow's milk protein allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:41.182518+00:00"}
{"study_id": 9675, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of cow's milk in the pathogenesis and management of eosinophilic esophagitis, focusing on its immunological mechanisms and therapeutic implications.", "results_summary": "Cow's milk proteins were identified as common triggers for eosinophilic esophagitis, with dietary elimination inducing histologic remission in over 60% of pediatric patients. However, variability in individual responses and gaps in understanding molecular mechanisms remain challenges.", "population_specificity": "Pediatric patients with eosinophilic esophagitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:41.520838+00:00"}
{"study_id": 9670, "supplement_id": 1054, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the nutritional safety and suitability of a specific protein hydrolysate derived from skimmed cow's milk and whey protein concentrates for use in infant and follow-on formula.", "results_summary": "The study found that the protein hydrolysate supported infant growth similarly to intact cow's milk protein, with no concerns raised about adverse events or tolerance. The Panel concluded it is nutritionally safe and suitable for infant and follow-on formula when meeting specified protein and compositional criteria.", "population_specificity": "Infants consuming the formula as the sole source of nutrition for 3 months.", "effective_dosage": "Protein content of 2.3 g/100 kcal in the hydrolysate formula, compared to 1.9 g/100 kcal in the intact protein formula.", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:42.108161+00:00"}
{"study_id": 9676, "supplement_id": 1054, "safety_score": "60", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness and parent perspectives of the cow's milk (CM) ladder as a therapy option for children with CM allergy.", "results_summary": "The study found that while the CM ladder was generally satisfactory, allergic reactions (primarily skin rashes) were common, and parents experienced anxiety and implementation challenges. Improvements were suggested, including diversifying food options and enhancing parental education to reduce anxiety.", "population_specificity": "Children with cow's milk and/or hen's egg allergy and their parents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:42.299149+00:00"}
{"study_id": 9677, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the clinical application of component resolved diagnosis in IgE-mediated cow's milk protein allergy, focusing on diagnosis, tolerance development, and personalized treatment.", "results_summary": "The study highlights the potential of component resolved diagnosis for improving the diagnosis and management of cow's milk protein allergy, including identifying co-sensitization and guiding personalized diets. It also discusses the need for more effective diagnostic methods beyond oral food challenges.", "population_specificity": "Infants and young children with IgE-mediated cow's milk protein allergy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:47.527723+00:00"}
{"study_id": 9682, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a diagnostic tool to assess the efficacy and responsiveness of oral immunotherapy (OIT) for cow's milk allergy by profiling allergen-specific IgE and IgG4 antibodies.", "results_summary": "The study identified 14 epitopes recognized by IgE and IgG4 in cow's milk allergens, which correlated with allergy severity and OIT efficacy. The developed immunochromatographic method demonstrated potential for diagnostic use in monitoring OIT treatment stages.", "population_specificity": "Patients with cow's milk allergy undergoing oral immunotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:48.957368+00:00"}
{"study_id": 9684, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate changes in gut microbiota, dietary patterns, and anthropometric variables in infants with cow's milk protein allergy (CMPA) after six months on a restrictive diet compared to healthy controls.", "results_summary": "No significant differences in growth were found, but dietary intake of some macro- and micronutrients differed. Breastfed CMPA infants had higher bifidobacteria and lipid intakes than those fed hydrolyzed formulas.", "population_specificity": "21 infants diagnosed with CMPA and 24 healthy infants.", "effective_dosage": "Not specified", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:49.963524+00:00"}
{"study_id": 9679, "supplement_id": 1054, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare gastrointestinal symptoms, growth trajectories, and hemoglobin levels in healthy infants fed cow's milk-based formula (CMF) versus goat milk-based formula (GMF).", "results_summary": "The study found no significant differences in gastrointestinal symptoms, growth parameters, or hemoglobin levels between infants fed CMF and GMF, with both groups showing low GI symptoms and adequate growth within WHO standards.", "population_specificity": "Healthy Brazilian infants aged 3 to 12 months.", "effective_dosage": "Not specified in the abstract.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:50.053579+00:00"}
{"study_id": 9686, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the growth of infants with cow's milk protein allergy (CMPA) fed with extensively hydrolyzed (EHFs) or amino acid-based (AAFs) formulas.", "results_summary": "The study found that growth criteria (weight, length, and head circumference) were suitable for both EHFs and AAFs groups and aligned with WHO growth charts, though the EHFs group showed higher growth rates compared to AAFs.", "population_specificity": "Infants with CMPA referred to a gastroenterology clinic, aged up to one year.", "effective_dosage": "Not specified", "study_duration": "Until one year of age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:50.819528+00:00"}
{"study_id": 9685, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess dairy consumption and vitamin D levels in adolescents with a history of cow's milk allergy (CMA) compared to controls to determine if CMA management affects long-term nutritional outcomes.", "results_summary": "The study found no significant differences in dairy consumption or vitamin D levels between adolescents with a history of CMA, those with refuted CMA, and controls, suggesting successful reintroduction of milk and adequate vitamin D sufficiency.", "population_specificity": "Adolescents aged 15-18 years with a history of CMA or refuted CMA in infancy, and age-matched controls.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 15-18 years after initial infancy study (1999-2002).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:51.992279+00:00"}
{"study_id": 9687, "supplement_id": 1054, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of dietary advancement therapy using a milk ladder versus complete avoidance of milk for managing IgE-mediated cow's milk protein allergy (CMPA).", "results_summary": "The study found that patients using the milk ladder were 3.67 times more likely to successfully reintroduce cow's milk compared to those avoiding milk, with fewer anaphylaxis incidents in the milk ladder group. Failure to complete treatment was linked to higher skin prick test results in the avoidance group and raised specific IgE in the milk ladder group.", "population_specificity": "371 pediatric patients with IgE-mediated CMPA treated between 2011 and 2020 in Ireland and Spain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:57.168352+00:00"}
{"study_id": 9688, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers sought to assess the rate of decline in cow's milk-specific IgE and component-resolved diagnostics after 1 year of Tolerance Induction Program (TIP) immunotherapy in children with cow's milk anaphylaxis.", "results_summary": "After 1 year of TIP immunotherapy, significant reductions were observed in cow's milk-specific IgE, component-resolved diagnostics, and eosinophil counts, while specific IgG4 increased. Adverse events were rare, demonstrating both safety and clinical efficacy.", "population_specificity": "214 cow's milk anaphylactic children treated at the Translational Pulmonary & Immunology Research Center/Food Allergy Institute.", "effective_dosage": "10-g dairy protein weekly.", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:57.863386+00:00"}
{"study_id": 9690, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to outline the treatment approach for cow's milk protein allergy, focusing on dietary elimination and appropriate formula options for infants.", "results_summary": "The study found that complete elimination of cow's milk protein is necessary for symptom remission and future tolerance, with extensively hydrolysed formulas recommended for mild/moderate cases and amino acid-based formulas for severe cases. Treatment duration and tolerance acquisition vary based on clinical and immunological factors.", "population_specificity": "Infants with cow's milk protein allergy, particularly formula-fed infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:58.105241+00:00"}
{"study_id": 9692, "supplement_id": 1054, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the complexities of cow's milk protein allergy (CMPA), including diagnostic challenges, clinical variability, and potential improvements in diagnostic accuracy through omics sciences.", "results_summary": "The study highlights the diagnostic and management challenges of CMPA due to inconsistent epidemiological data, complex terminology, and difficulties in differential diagnosis. It suggests that integrating omics sciences could improve diagnostic accuracy and treatment prediction.", "population_specificity": "Pediatric age groups, particularly infants in their first year of life.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:00.175488+00:00"}
{"study_id": 9689, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare expert opinions from the Middle East and ESPGHAN on the diagnosis and management of cow's milk allergy (CMA).", "results_summary": "Experts generally agreed on symptoms not suggestive of CMA, the use of amino-acid based formula for severe cases, and insufficient evidence for probiotics/prebiotics in elimination diets. Differences in opinion existed regarding hydrolysed rice formula and soy-based formula, influenced by regional availability and cultural factors.", "population_specificity": "Expert groups from the Middle East (n=14) and ESPGHAN (n=13).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:00.598208+00:00"}
{"study_id": 9691, "supplement_id": 1054, "safety_score": "70", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety and efficacy of oral immunotherapy (OIT) with hydrolyzed milk formulas as an alternative treatment for persistent cow's milk allergy (CMA).", "results_summary": "A 12-year-old girl with severe CMA successfully consumed 300 mL of unhydrolyzed cow's milk after 3.5 years of OIT, with consistent consumption of over 200 mL for six months without symptom recurrence, despite some allergic reactions during treatment.", "population_specificity": "12-year-old girl with severe cow's milk allergy.", "effective_dosage": "Gradually increasing intake of hydrolyzed and partially hydrolyzed milk, culminating in 300 mL of unhydrolyzed cow's milk.", "study_duration": "3.5 years of OIT.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:00.886751+00:00"}
{"study_id": 9693, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the most suitable specialized formulas (with or without probiotics) for managing cow's milk allergy (CMA) in infants who are not breastfed.", "results_summary": "The WAO guideline panel suggested extensively hydrolyzed cow's milk formula or hydrolyzed rice formula as first options for managing CMA, with amino acid and soy formulas as secondary choices. They also noted that formulas with or without probiotics (specifically Lacticaseibacillus rhamnosus GG) could be considered, but recommendations were conditional due to low certainty in the evidence.", "population_specificity": "Infants with immunoglobulin E (IgE) and non-IgE-mediated cow's milk allergy who are not breastfed.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:06.913854+00:00"}
{"study_id": 9694, "supplement_id": 1054, "safety_score": "40", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the biological and microbiological quality of bulk tank milk and freshly milked raw milk, as well as assess antimicrobial resistance in bacteria isolated from milk samples.", "results_summary": "The study found that none of the farms met Brazilian biological quality standards for bulk tank milk, and freshly milked raw milk showed varying levels of mastitis (clinical, subclinical, or none). Most samples had acceptable microbiological quality, but antimicrobial resistance was prevalent in Enterobacteriaceae and Staphylococcus spp., including multidrug-resistant strains.", "population_specificity": "Dairy cattle and their milk samples in Brazil.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:07.051513+00:00"}
{"study_id": 9695, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess out-of-pocket expenses and parent-reported quality of life (QoL) in children aged 0-5 diagnosed with cow's milk protein allergy.", "results_summary": "The study found that QoL scores were higher (indicating lower QoL) in children with additional food allergies and older age groups, but were not correlated with out-of-pocket expenses. About 17% of families spent over 15% of their monthly income on treatment-related costs, which varied significantly if formulas were included.", "population_specificity": "Children aged 0-5 with cow's milk protein allergy in Bogot\u00e1, Colombia (71% female, median age 17 months).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:07.447539+00:00"}
{"study_id": 9678, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of cow's milk tolerance acquisition and synbiotic supplementation on the fecal metabolome in infants with IgE-mediated cow's milk allergy.", "results_summary": "The study found that synbiotic supplementation altered the fecal metabolome after 6 months, including changes in purine, bile acid, and unsaturated fatty acid levels, and increased metabolites linked to Bifidobacterium activity. However, no clear conclusion was reached regarding the impact of cow's milk tolerance acquisition on the fecal metabolome.", "population_specificity": "Infants with IgE-mediated cow's milk allergy.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:07.883279+00:00"}
{"study_id": 9698, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the role of exosome biogenesis in cow's milk allergy (CMA) response and the effects of inhibiting exosome release using GW4869.", "results_summary": "Inhibition of exosome release with GW4869 reduced Th2-related immune responses, decreased histamine and allergen-specific IgE levels, and lowered Th1, Th2, and Th17 cell expression, suggesting exosomes play a role in CMA development.", "population_specificity": "BALB/c mice sensitized with cow's milk proteins.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:09.101869+00:00"}
{"study_id": 9696, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether amino acid-based formulas with or without synbiotics affected the development of tolerance to cow's milk in early life.", "results_summary": "The study found no significant difference in cow's milk tolerance development between groups receiving amino acid-based formula with synbiotics (78%) and without synbiotics (74%), suggesting that neither intervention slowed tolerance acquisition compared to natural outgrowth of cow's milk allergy.", "population_specificity": "Subjects with a mean age of 3.8 years who had previously consumed amino acid-based formulas during a 1-year intervention in early life.", "effective_dosage": "Not specified", "study_duration": "1-year intervention period, with follow-up at 36 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:10.356952+00:00"}
{"study_id": 9697, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the diagnosis, management, and treatment options for cow's milk allergy (CMA) in early childhood, including IgE and non-IgE mediated forms.", "results_summary": "The study found that CMA is complex and can present in various forms, with individualized avoidance advice and replacement options like hypoallergenic formulas or plant-based milk being key. Immunotherapy and baked milk strategies show promise but carry risks and uncertain long-term outcomes.", "population_specificity": "Children with cow's milk allergy (CMA) in early childhood.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:10.562121+00:00"}
{"study_id": 9683, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the resolution rates of IgE-mediated cow's milk allergy (IgE-CMA) by late adolescence and identify risk factors for its persistence.", "results_summary": "By age 17, 35% of the initially persistent IgE-CMA cases resolved spontaneously, with an overall resolution rate of 72.2%. Risk factors for persistence included larger SPT wheal size at diagnosis, lack of cow's milk formula feeding in infancy, and wheezing or anaphylaxis during initial reactions.", "population_specificity": "23 patients from a cohort of 54 diagnosed with IgE-CMA at birth, followed until age 17.", "effective_dosage": "Not specified", "study_duration": "Follow-up until age 17", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:13.544853+00:00"}
{"study_id": 9700, "supplement_id": 1054, "safety_score": "70", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to update guidelines on the diagnosis, treatment, and prevention of cow's milk allergy (CMA), focusing on gastrointestinal manifestations and addressing over-diagnosis concerns.", "results_summary": "The study found that CMA is over-diagnosed in both breastfed and formula-fed infants, with common symptoms like stool changes or feeding aversion often misinterpreted as CMA. It emphasized the need for a challenge test after a short elimination diet as a diagnostic cornerstone.", "population_specificity": "Infants (both exclusively breastfed and formula/mixed-fed) with suspected cow's milk allergy.", "effective_dosage": "Not Assessed", "study_duration": "Diagnostic elimination diet of 2-4 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:15.966791+00:00"}
{"study_id": 9699, "supplement_id": 1054, "safety_score": "75", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the dose, efficacy, and safety of epicutaneous immunotherapy with Viaskin milk in children with IgE-mediated cow's milk allergy.", "results_summary": "The study found that a 300-\u03bcg dose of Viaskin milk showed the highest response rate (49.0%) compared to placebo (30.2%), particularly in children aged 2-11 years. Most adverse events were mild or moderate application-site reactions, with one case of treatment-related anaphylaxis in the 500-\u03bcg group.", "population_specificity": "Children aged 2-17 years with IgE-mediated cow's milk allergy.", "effective_dosage": "150 \u03bcg, 300 \u03bcg, or 500 \u03bcg of Viaskin milk daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:16.318983+00:00"}
{"study_id": 9701, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of the gut microbiome in cow's milk allergy (CMA) development and assess the effects of probiotic and prebiotic interventions.", "results_summary": "The study found that CMA is associated with specific gut microbiome alterations, including reduced Lactobacillales and Bifidobacterium levels, and altered metabolite profiles. Probiotic interventions, particularly Bifidobacterium, showed potential in restoring gut balance and immune response, though results for other taxa were inconclusive.", "population_specificity": "Children with IgE-mediated cow's milk allergy and animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:16.901794+00:00"}
{"study_id": 9702, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of cow's milk elimination (CME) as a primary treatment for eosinophilic esophagitis (EoE) in children, focusing on histologic remission, clinical findings, and quality of life.", "results_summary": "CME achieved histologic remission in 50%-65% of children with EoE, improved clinical symptoms observed via endoscopy, and enhanced self-reported quality of life. It was deemed a viable primary treatment for some children with EoE.", "population_specificity": "Children aged 2-18 years with eosinophilic esophagitis (EoE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:17.120970+00:00"}
{"study_id": 9703, "supplement_id": 1054, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to explore the benefits and challenges of cow's milk consumption, focusing on lactose intolerance (LI) and cow's milk protein allergy (CMPA), and advocated for personalized nutrition approaches.", "results_summary": "The study highlights cow's milk as a beneficial food but notes challenges for lactose-intolerant and allergic individuals. It proposes precision nutrition (PN) to tailor dietary strategies based on individual genetic, metabolic, and microbiota profiles to improve quality of life.", "population_specificity": "Individuals of all ages, with specific focus on those with lactose intolerance (LI) or cow's milk protein allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:18.250061+00:00"}
{"study_id": 9706, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop expert consensus on the diagnosis and treatment of Cow's Milk Protein Allergy (CMPA) in children under 2 years of age in Mexico.", "results_summary": "Consensus was reached on all diagnostic and treatment items, leading to an algorithm that reduces unnecessary diagnostic studies, promotes breastfeeding, and recommends hypoallergenic formulas when needed, along with guidelines for treatment duration and gradual reintroduction of cow's milk protein.", "population_specificity": "Children under 2 years of age with Cow's Milk Protein Allergy (CMPA) in Mexico.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:19.216683+00:00"}
{"study_id": 9705, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the mechanisms behind IgE-mediated cow's milk allergy (IgE-CMA) and identify potential biomarkers and treatment strategies by studying gut dysbiosis and metabolic alterations.", "results_summary": "The study found that gut dysbiosis precedes allergic inflammation in IgE-CMA, with microbial metabolic changes (e.g., bile acid, energy, and tryptophan metabolites) linked to low-grade inflammation in children on elimination diets. These findings were corroborated in both murine models and human cohorts.", "population_specificity": "Mice (BALB/c and C57Bl/6 strains) and children with IgE-CMA (n=22) and healthy controls (n=23).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:20.606339+00:00"}
{"study_id": 9707, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of pasteurized cow's milk fortified with albumin protein on anthropometric indices in underweight primary-school children.", "results_summary": "The study found that cow's milk fortified with albumin significantly improved weight-for-age z-score and BMI-for-age z-score in underweight children, while the control group showed no significant changes. The albumin group demonstrated better outcomes compared to the control group in these indices.", "population_specificity": "Primary-school children aged 7-13 years with mild to moderate underweight (-1\u2265 weight-for-age z-score \u2265-3) in Yasuj, Iran.", "effective_dosage": "200 cc of milk with 10 g of albumin powder daily.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:22.666734+00:00"}
{"study_id": 9708, "supplement_id": 1054, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the pathophysiological characteristics, diagnosis, and treatment of cow's milk protein intolerance with preterm necrotizing enterocolitis (NEC).", "results_summary": "The study found that cow's milk protein intolerance in infants ranges from mild gastrointestinal symptoms to severe sepsis-like episodes, with a prevalence of 1.9%-4.9%. It also highlighted the difficulty in distinguishing between cow's milk protein intolerance and NEC in some cases.", "population_specificity": "Healthy term infants, preterm neonates, and late preterm infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:24.460080+00:00"}
{"study_id": 9711, "supplement_id": 1054, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze nutritional parameters of cow's milk and characterize carbapenemase-producing Klebsiella pneumoniae isolates in bovine mastitic milk.", "results_summary": "The study found a 25.71% prevalence of K. pneumoniae in bovine mastitis, with 44.4% being carbapenemase producers. Nutritional analysis showed fat (2.99%), protein (2.78%), lactose (4.32%), and total solids (11.34%) content.", "population_specificity": "Bovine mastitic cow's milk samples (n=700).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:26.334899+00:00"}
{"study_id": 9709, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the evidence for and against maternal cow's milk elimination diets in lactating mothers to manage cow's milk allergy in breastfed infants.", "results_summary": "The study found limited high-quality evidence supporting maternal cow's milk elimination, recommending it only in specific cases (IgE-mediated allergy, non-IgE-mediated symptoms, or severe eczema). It emphasized the need for careful reintroduction to confirm symptom resolution and highlighted potential nutritional and quality-of-life impacts on mothers.", "population_specificity": "Exclusively breastfed infants diagnosed with cow's milk allergy and their lactating mothers.", "effective_dosage": "Not specified", "study_duration": "2-4 week trial of maternal cow's milk elimination, followed by 1-week reintroduction.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:26.403778+00:00"}
{"study_id": 9710, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the relationship between IgE-mediated cow's milk protein allergy (CMPA) persistence and major cow's milk allergens, focusing on natural tolerance development in pediatric patients.", "results_summary": "61% of patients achieved natural tolerance to cow's milk after strict avoidance, but higher casein IgE levels were associated with failure to develop tolerance. Allergic reactions, including anaphylaxis, were common but not predicted by IgE levels.", "population_specificity": "Pediatric patients (200 children) diagnosed with IgE-mediated CMPA in Spain between 2011 and 2020.", "effective_dosage": "Not specified", "study_duration": "Not specified (retrospective analysis over 9 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:26.544547+00:00"}
{"study_id": 9712, "supplement_id": 1054, "safety_score": "60", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the viability of Cryptosporidium parvum in cow's milk after heat treatment (pasteurization and boiling) using the PMA-qPCR method.", "results_summary": "The study found that live C. parvum oocysts could be detected in pasteurized milk, while boiling effectively eliminated viable oocysts. The PMA-qPCR method successfully differentiated live from dead oocysts.", "population_specificity": "Contaminated raw cow's milk samples (not human subjects).", "effective_dosage": "50 ml of unpasteurized cow's milk contaminated with 5 X 10^5 C. parvum oocysts.", "study_duration": "Heat treatments were applied for seconds (pasteurization) or minutes (boiling).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:28.013644+00:00"}
{"study_id": 9713, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the resolution of symptoms in infants newly diagnosed with Cow's Milk Protein Allergy (CMPA) treated with extensively hydrolyzed formulas (EHF) with synbiotics and assess the treatment's impact on family quality of life.", "results_summary": "The study found that 95.4% of infants showed improvement or disappearance of symptoms after 4 weeks, with significant reductions in gastrointestinal and dermatological symptoms, regurgitation, and improved stool consistency and sleep patterns. Family quality of life also improved significantly.", "population_specificity": "Infants diagnosed with or suspected to have Cow's Milk Protein Allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:28.638977+00:00"}
{"study_id": 9714, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the immunological reactions, diagnostic methods, and management strategies for cow's milk allergy, including its prevalence, symptoms, and treatment options.", "results_summary": "The study found that cow's milk allergy is common in infants (0.5%-3% prevalence) with varied symptoms, and diagnosis relies on elimination diets or oral challenges. Management involves allergen elimination, with tolerance developing over time, and newer treatments like oral immunotherapy for IgE-mediated cases.", "population_specificity": "Infants (1 year of life) and individuals with cow's milk allergy.", "effective_dosage": "Not specified", "study_duration": "Follow-up reintroduction attempts every six months after one year of elimination diet.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:30.279294+00:00"}
{"study_id": 9715, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 75, "study_goal": "The researchers aimed to evaluate healthcare providers' clinical experience and satisfaction with hypoallergenic formulas (eHF-LGG and AAF) for managing suspected cow's milk protein allergy (CMPA) in infants.", "results_summary": "Clinicians reported high satisfaction (95-97%) and expected clinical results (93-97%) with both hypoallergenic formulas, with few patients requiring formula switches after initiation.", "population_specificity": "Infants under six months old with suspected CMPA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:31.064157+00:00"}
{"study_id": 9716, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze Spanish pediatricians' perspectives on the prevention and nutritional management of cow's milk protein allergy (CMPA).", "results_summary": "The study found that pediatricians generally agreed on using extensively hydrolyzed formulas (eHFs) for CMPA prevention in high-risk atopic children, despite limited evidence. However, there was no consensus on the role of probiotics and prebiotics in tolerance development, and management approaches varied based on clinician experience.", "population_specificity": "222 primary care and hospital pediatricians in Spain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:33.387488+00:00"}
{"study_id": 9717, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review nutritional strategies for preventing and managing pediatric cow's milk allergy (CMA) and propose a supplement to address nutrient deficiencies and influence disease course.", "results_summary": "The study highlights the increasing prevalence and severity of CMA, emphasizing the role of diet as a modifiable factor for prevention and treatment. It proposes a comprehensive supplement to prevent nutrient deficiencies and positively impact CMA outcomes.", "population_specificity": "Pediatric patients with cow's milk allergy (CMA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:34.129508+00:00"}
{"study_id": 9718, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to develop and evaluate a two-step hydrolysis hypoallergenic formula to reduce allergenicity in cow's milk for infants with cow's milk allergy (CMA).", "results_summary": "The study found that 97.14% of hydrolyzed peptides from \u03b1-lactalbumin and \u03b2-lactoglobulin lacked allergenic epitopes after treatment, significantly reducing allergenicity in vitro and in vivo. The hypoallergenic formula induced lower basophil degranulation and alleviated anaphylactic symptoms compared to common milk powder.", "population_specificity": "Infants with cow's milk allergy (CMA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:35.012146+00:00"}
{"study_id": 9720, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of oral immunotherapy (OIT) for desensitization and remission in IgE-mediated cow's milk allergy.", "results_summary": "The study found strong evidence that cow's milk OIT can induce desensitization (RR 13.98), but there was an increased risk of allergic reactions and adrenaline use (RR 8.45). Evidence for sustained unresponsiveness (remission) was not reported for cow's milk.", "population_specificity": "Individuals with IgE-mediated cow's milk allergy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:36.916043+00:00"}
{"study_id": 9719, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of a whey-based extensively hydrolyzed formula supplemented with 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) on the fecal microbiome and metabolome in infants with cow's milk protein allergy (CMPA).", "results_summary": "The study found that HMO supplementation enriched bifidobacteria in the gut microbiome, delayed the shift toward an adult-like microbiome pattern, and partially corrected dysbiosis in infants with CMPA. Specific changes in fecal amino acid degradation and bile acid conjugation were observed, particularly in infants starting the supplement before three months of age.", "population_specificity": "Non-breastfed infants with cow's milk protein allergy (CMPA) up to 12 months of age.", "effective_dosage": "Not specified (supplemented with 2'-FL and LNnT).", "study_duration": "Up to 12 months of age (with fecal samples collected at baseline, 1, 3, and 12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:38.162050+00:00"}
{"study_id": 9724, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine factors, including COVID-19, affecting formula compliance in infants with Cow's Milk Protein Allergy (CMPA).", "results_summary": "The study found a low compliance rate (30.8%) for formula-based treatment, with breastfeeding duration, daily formula amount, and sweetener addition reducing compliance. No significant correlation was found between formula adherence and the pandemic.", "population_specificity": "Infants aged 6 months to 2 years with IgE-mediated CMPA in Turkey.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:39.023516+00:00"}
{"study_id": 9721, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of replacing non-fat dry milk in cow's milk with galactomannans (commercial, guar, and microbial) on yoghurt quality and probiotic activity.", "results_summary": "Yoghurt supplemented with galactomannans showed increased acidity, curd tension, total solids, and bifidobacteria counts, along with reduced pH and syneresis, while maintaining similar fat, protein, and ash content compared to the control. Organoleptic scores were also higher in galactomannan-supplemented yoghurts.", "population_specificity": "Not specified (yoghurt production study, no human subjects mentioned).", "effective_dosage": "0.15% and 0.25% of commercial, guar, and microbial galactomannan.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:39.047118+00:00"}
{"study_id": 9723, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of different feeding patterns (exclusive breastfeeding, partially hydrolyzed formula, or standard formula) on the incidence of cow's milk protein allergy, atopic dermatitis, and growth in high-risk infants.", "results_summary": "The study found that partially hydrolyzed formula-fed infants had a significantly lower incidence of atopic dermatitis (6.5%) compared to exclusively breastfed infants (22.7%). Cow's milk protein allergy incidence was also lower in the partially hydrolyzed formula group when adjusted for high breast milk intake. Growth did not differ between groups.", "population_specificity": "551 high-risk infants with a family history of allergy from 3 European countries.", "effective_dosage": "Not specified (feeding regimens included exclusive breastfeeding, partially hydrolyzed formula, or standard formula).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:40.324879+00:00"}
{"study_id": 9725, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the impact of hypoallergenic formulas on the nutritional status of infants with cow's milk protein allergy (CMPA).", "results_summary": "The study found significant improvements in anthropometric indexes (weight/age, height/age, BMI) among infants with CMPA after hypoallergenic formula treatment, though there was an increase in infants classified as at risk of overweight or obese. Preterm infants and those receiving nutritional counseling showed distinct outcomes in nutritional status evolution.", "population_specificity": "Infants (n=1036) with CMPA participating in a governmental program in Brazil.", "effective_dosage": "Not specified", "study_duration": "Not specified (assessed before and after treatment, but exact duration not stated)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:43.478801+00:00"}
{"study_id": 9727, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the relationship between facial dermatitis and food sensitization to cow's milk in early childhood, exploring whether aggressive treatment of facial dermatitis could prevent food sensitization.", "results_summary": "The study found that by 3 years of age, children with facial atopic dermatitis (AD) had 48% greater food sensitization levels to cow's milk compared to children without facial involvement of AD. The abstract suggests a potential link but does not confirm causality or allergy development.", "population_specificity": "Infants and young children with atopic dermatitis (AD), specifically those with facial involvement.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:43.507445+00:00"}
{"study_id": 9726, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the tolerability and immune tolerance acquisition in children with IgE-mediated cow's milk allergy (CMA) when switching from amino acid-based formula (AAF) to extensively hydrolyzed casein formula containing Lacticaseibacillus rhamnosus GG (EHCF + LGG).", "results_summary": "The study found that 98% of children tolerated EHCF + LGG initially, and after 12 months, the EHCF + LGG group had a significantly higher rate of immune tolerance acquisition (48%) compared to the AAF group (3%). Normal body growth was observed in both groups.", "population_specificity": "Children with IgE-mediated cow's milk allergy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:43.887532+00:00"}
{"study_id": 9728, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the use of amino acid-based formulas (AAF) as a therapeutic option for severe cow's milk allergy (CMA) in cases where extensively hydrolyzed formulas (EHF) are ineffective.", "results_summary": "The study found that AAFs are recommended as the first therapeutic option in severe CMA cases, including anaphylaxis, severe food protein-induced enterocolitis syndrome, multiple food allergies, and eosinophilic esophagitis unresponsive to exclusion diets. AAFs were highlighted for their absence of residual allergenicity, making them a safe and effective alternative for severe CMA patients.", "population_specificity": "Breast-fed and formula-fed infants with severe cow's milk allergy (CMA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:47.699143+00:00"}
{"study_id": 9730, "supplement_id": 1054, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate and compare the efficacy, safety, and immunological effects of three management strategies for IgE-mediated cow's milk protein allergy (CMPA): avoidance, the milk ladder, and oral immunotherapy (OIT).", "results_summary": "The study found that avoidance protects against allergic reactions until natural tolerance occurs, the milk ladder successfully helps most CMPA patients, and OIT protocols show decreased IgE and increased IgG4 levels along with reduced wheal size diameter. These strategies were deemed safe and effective, though future trials are needed for direct comparison.", "population_specificity": "Pediatric populations with IgE-mediated cow's milk protein allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:47.898583+00:00"}
{"study_id": 9731, "supplement_id": 1054, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify clinical phenotypes and therapeutic measures for cow's milk anaphylaxis (CMA) compared to hen's egg anaphylaxis (HEA) in children up to 12 years of age.", "results_summary": "The study found that cow's milk anaphylaxis (CMA) in children was characterized by more frequent respiratory symptoms but less frequent cardiovascular symptoms compared to hen's egg anaphylaxis (HEA). Adrenaline was underused and its administration varied significantly by country.", "population_specificity": "Children up to 12 years of age from 10 European countries and Brazil.", "effective_dosage": "Not mentioned", "study_duration": "Data collected from 2007 to 2020 (retrospective analysis).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:48.102006+00:00"}
{"study_id": 9732, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of Bifidobacteria probiotics on immune tolerance modulation in children with cow's milk allergy (CMA).", "results_summary": "Probiotic treatment reduced naive and activated CD4+ T cells and decreased basophil degranulation, suggesting improved immune tolerance to cow's milk proteins. These effects persisted even after the probiotic wash-out period.", "population_specificity": "Pediatric patients with cow's milk allergy (CMA).", "effective_dosage": "Not specified", "study_duration": "45 days of treatment, followed by 45 days of wash-out.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:48.165142+00:00"}
{"study_id": 9729, "supplement_id": 1054, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and compliance of raw milk and its derivatives (Lben and Raib) sold in the informal sector of Morocco's Doukkala region.", "results_summary": "The study found high non-compliance rates with microbiological and physicochemical standards in raw milk (65%), Lben (70%), and Raib (40%), indicating significant safety risks for consumers. pH values and other characteristics also failed to meet international criteria.", "population_specificity": "Informal milk sellers and consumers in the El Jadida Province, Morocco.", "effective_dosage": "Not specified", "study_duration": "Samples were collected between January 1st, 2021, and October 30th, 2021.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:48.849037+00:00"}
{"study_id": 9733, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether prebiotic kestose could induce tolerance to cow's milk protein in children with severe cow's milk allergy by altering gut microbiota.", "results_summary": "Kestose treatment significantly increased the threshold dose for milk protein, reduced milk- and casein-specific IgE levels, and increased the abundance of Fusicatenibacter spp. in the gut, which correlated inversely with IgE levels.", "population_specificity": "Children diagnosed with severe cow's milk allergy.", "effective_dosage": "Daily ingestion of baked milk (bread or cookies) with or without kestose (exact dosage not specified).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:52.268617+00:00"}
{"study_id": 9735, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the best cut-off point of the Cow's Milk-related Symptom Score (CoMiSS) for diagnosing cow's milk allergy (CMA) in infants and explore additional parameters to improve its accuracy.", "results_summary": "The study found that a CoMiSS score of \u226512 was the best cut-off for predicting CMA, with 76.19% sensitivity and 62.50% specificity. Symptoms like mucoid stool, bloody stool, and faltering growth improved significantly after a cow milk-free diet (CMFD) in confirmed CMA infants.", "population_specificity": "100 infants with CMA-suggestive symptoms.", "effective_dosage": "Not specified (cow milk-free diet).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:53.693032+00:00"}
{"study_id": 9734, "supplement_id": 1054, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether a novel heated cow milk protein (iAGE product) could accelerate tolerance induction in children with cow's milk allergy (CMA).", "results_summary": "The study found that 73% of children in the treatment group tolerated cow's milk after 8 months, increasing to 82% after 24 months, compared to 57% and 71% in the control group. SIgE levels for cow's milk decreased in both groups, and no product-related adverse events were reported.", "population_specificity": "18 children with CMA (mean age 12.8 months in treatment group, 17.6 months in control group), including some with multiple food allergies.", "effective_dosage": "Daily consumption of the iAGE product (specific dosage not detailed).", "study_duration": "24 months (with assessments at 8, 16, and 24 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:55.476897+00:00"}
{"study_id": 9736, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the applicability, usability, and accuracy of the Nutricate\u00a9 online application for managing dietary intake in children with cow's milk allergy (CMA).", "results_summary": "The Nutricate\u00a9 tool showed very good concordance with the reference method (NutriLog\u00a9) for assessing micro/macronutrient intake, with significant correlations and no bias. The tool's usability was rated as excellent.", "population_specificity": "30 children with cow's milk allergy (CMA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:56.406148+00:00"}
{"study_id": 9739, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate whether omalizumab therapy could increase tolerance to cow's milk in a patient with severe cow's milk allergy.", "results_summary": "Under omalizumab therapy, the patient showed increased tolerance to cow's milk (14 mL tolerated), but adverse reactions (urticaria, dyspnea, angioedema) occurred at 30 mL. The therapy may help prevent severe reactions from accidental consumption.", "population_specificity": "22-year-old male with severe cow's milk allergy and history of anaphylactic reactions.", "effective_dosage": "Omalizumab (3 \u00d7 150 mg/month SC) and cetirizine 10 mg once daily.", "study_duration": "Long-term (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:57.710061+00:00"}
{"study_id": 9737, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy of incremental cow's milk loading as a treatment for lactose malabsorption in Japanese individuals with lactose intolerance symptoms.", "results_summary": "The study found that incremental cow's milk loading improved symptoms in 90.6% of subjects, though only 34.5% showed improved diagnostic values for lactose malabsorption. Fecal microbiota analysis revealed a significant increase in Blautia in symptom-free subjects.", "population_specificity": "Japanese individuals (ages 10-68) with lactose intolerance symptoms and diagnosed lactose malabsorption.", "effective_dosage": "Incremental loads starting from 30 mL, increasing up to 200 mL at 4-7 day intervals.", "study_duration": "Mean treatment period was 41 \u00b1 8.6 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:57.979129+00:00"}
{"study_id": 9738, "supplement_id": 1054, "safety_score": "75", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and feasibility of combining heat-killed Lactiplantibacillus plantarum YIT 0132 (LP0132) with low-dose oral immunotherapy for treating IgE-mediated cow milk allergy (CMA).", "results_summary": "The study found that 41.4% of participants in the LP0132 group and 37.9% in the control group showed improved tolerance to cow milk. The LP0132 group had significantly higher sIgG4 levels, lower IL-5 and IL-9 levels, and increased gut microbiota diversity compared to the control group.", "population_specificity": "Children aged 1-18 years with IgE-mediated cow milk allergy (n=61).", "effective_dosage": "Low-dose slow oral immunotherapy with cow milk (specific dosage not detailed).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:58.326555+00:00"}
{"study_id": 9740, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate cow milk's impact on breast carcinogenesis by examining epidemiological evidence and molecular signaling pathways related to breast cancer pathogenesis.", "results_summary": "The study found an association between cow's milk consumption and increased risk of estrogen receptor-\u03b1-positive breast cancer, attributing this to milk's promotion of IGF-1, insulin, and estrogen signaling, along with potential oncogenic components like exosomal microRNAs and environmental contaminants. The review highlights the need for further studies considering vulnerable periods of breast carcinogenesis and milk processing methods.", "population_specificity": "Individuals with BRCA1 loss-of-function mutations and FTO/IGF1 gain-of-function polymorphisms, as well as general populations consuming commercial milk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:58.395718+00:00"}
{"study_id": 9741, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the immunological mechanisms of non-IgE-mediated cow's milk protein allergy (CMPA) and identify immunoreactive proteins in a pediatric patient group.", "results_summary": "The study found no specific IgE in CMPA patients but observed a significant increase in antigen-specific IgG1, identifying 11 proteins that bound to IgG1. These findings suggest IgG1 may serve as an early signal for potential risk of developing IgE-mediated food allergy.", "population_specificity": "Mexican pediatric patients (n = 34) with non-IgE-mediated CMPA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:00.842022+00:00"}
{"study_id": 9742, "supplement_id": 1054, "safety_score": "70", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of oral immunotherapy (OIT) for inducing cow's milk tolerance in children with cow's milk allergy (CMA).", "results_summary": "The study found that OIT was relatively safe, with a low reaction rate, and nearly two-thirds of subjects achieved tolerance to cow's milk. Reactions were linked to high IgE levels.", "population_specificity": "Children with cow's milk allergy managed by a third-level pediatric allergy center.", "effective_dosage": "Increasing milk quantities until tolerance was achieved (specific amounts not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:02.877549+00:00"}
{"study_id": 9744, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the gut microbiome in the development of cow's milk allergy (CMA) and discuss potential microbiome-based strategies for its prevention and treatment.", "results_summary": "The study highlights that gut microbiome dysbiosis in early life may contribute to immune dysregulation and increase susceptibility to CMA, suggesting microbiome modification as a potential preventive or therapeutic approach.", "population_specificity": "Infancy and early childhood (specific to cow's milk allergy).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:04.400875+00:00"}
{"study_id": 9743, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the use and position of hydrolyzed rice formulas (HRF) in managing cow's milk allergy (CMA) and to develop expert consensus on their indications.", "results_summary": "The study found that HRF is a suitable first-line alternative to cow's milk-based extensively hydrolyzed formulas (eHF) or amino acid-based formulas (AAF) for managing CMA, with proven hypoallergenicity and growth support comparable to other hypoallergenic formulas. Experts reached 100% agreement on eight consensus statements supporting HRF use in CMA management.", "population_specificity": "Infants with cow's milk allergy (CMA), including both IgE-mediated and non-IgE-mediated cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:05.261809+00:00"}
{"study_id": 9747, "supplement_id": 1054, "safety_score": "65", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the clinical efficacy and safety of oral immunotherapy (OIT) in treating children with immunoglobulin E-mediated cow's milk allergy (IMCMA).", "results_summary": "OIT led to desensitization in 72.7% of treated children compared to 21.6% in controls, with particularly strong effects in children over 3 years old. Adverse effects were common but mostly mild, though epinephrine use was more frequent in the OIT group.", "population_specificity": "Children with immunoglobulin E-mediated cow's milk allergy (IMCMA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:07.040949+00:00"}
{"study_id": 9746, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether oral desensitization with Ketocal\u00ae could enable infants with cow's milk protein allergy to safely use a ketogenic diet for epilepsy treatment.", "results_summary": "The study found that oral desensitization with Ketocal 3:1\u00ae allowed its use in the diet, leading to seizure control and clinical improvement in an infant with cow's milk protein allergy. The approach also suggested a probable resolution of the allergy.", "population_specificity": "Infant with drug-refractory epileptic encephalopathy and IgE-mediated cow's milk protein allergy.", "effective_dosage": "Ketocal 3:1\u00ae (specific dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:07.114380+00:00"}
{"study_id": 9748, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the body growth pattern in children with IgE-mediated cow's milk protein allergy (CMPA) treated with a new amino acid-based formula (AAF) for 6 months.", "results_summary": "The study found that the new AAF ensured normal growth in CMPA patients, with growth patterns similar to healthy controls. The formula was well-tolerated, with optimal adherence and no reported adverse events related to its use.", "population_specificity": "15 Caucasian infants with IgE-mediated CMPA (80% male, mean age 16.7 months at enrollment, 80% with familial allergy risk).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:07.517549+00:00"}
{"study_id": 9745, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the association between cow's milk consumption and Protein-losing enteropathy (PLE) combined with severe iron deficiency anemia (IDA) in infants and toddlers.", "results_summary": "The study found that early complete elimination of cow's milk protein led to faster normalization of hemoglobin, albumin, and eosinophil counts compared to reduced intake or no dietary change. The results suggest cow's milk protein may contribute to PLE with IDA through non-IgE-mediated immune reactions.", "population_specificity": "Infants and toddlers aged 7.0-26.7 months diagnosed with PLE and IDA.", "effective_dosage": "Median daily intake was 700 mL (range, 300-900 mL) of powdered formula or whole cow's milk.", "study_duration": "Median follow-up duration was 9.4 months (range, 1.3-18.0 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:11.517677+00:00"}
{"study_id": 9751, "supplement_id": 1054, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the immune mechanisms underlying hypersensitivity reactions to cow's milk, particularly focusing on atopic dermatitis (AD) as a manifestation, and to review current and future treatment options.", "results_summary": "The study highlights that cow's milk can trigger type I and IV hypersensitivity reactions, worsening atopic dermatitis, and emphasizes the need for early diagnosis and appropriate treatment.", "population_specificity": "Individuals with cow's milk allergy (CMA) and atopic dermatitis (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:11.979844+00:00"}
{"study_id": 9750, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate fecal calprotectin (FC) as a biomarker for diagnosing and monitoring cow's milk protein allergy (CMPA).", "results_summary": "The study found that FC levels were significantly higher in children with CMPA compared to healthy controls and decreased after elimination diet treatment, suggesting FC could be a reliable biomarker for CMPA diagnosis and therapy response prediction.", "population_specificity": "Children with cow's milk protein allergy (CMPA) and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:14.064454+00:00"}
{"study_id": 9752, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to quantify the wider economic impact of cow's milk allergy (CMA) and its management in the UK.", "results_summary": "Children with CMA required significantly more medications and healthcare contacts compared to controls, resulting in additional healthcare costs of \u00a31381.53 per person per year. CMA was associated with a higher healthcare burden due to increased prescribing and medical consultations.", "population_specificity": "3,499 children with CMA (mean age at diagnosis 4.04 months) and 3,499 matched controls without CMA in the UK.", "effective_dosage": "Not specified", "study_duration": "Mean observation period of 4.2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:14.376848+00:00"}
{"study_id": 9749, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of IL-12, IL-16, and IL-17A on diagnosing and monitoring Cow's Milk Protein Allergy (CMPA) in children for clinical treatment.", "results_summary": "Infants with CMPA showed decreased IL-12 and increased IL-16 and IL-17A levels compared to healthy controls, with significant correlations to sIgE levels. After three months of milk avoidance treatment, IL-12 levels increased while IL-16 and IL-17A levels decreased, indicating these cytokines as valuable markers for monitoring CMPA.", "population_specificity": "158 infants with CMPA and 89 healthy babies, all younger than 9 months.", "effective_dosage": "Not specified", "study_duration": "Three months of milk avoidance treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:14.422387+00:00"}
{"study_id": 9754, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to highlight a rare but severe case of Cow's Milk Protein Allergy (CMPA) in a neonate presenting with methaemoglobinaemia and metabolic acidosis.", "results_summary": "The study found that CMPA can lead to life-threatening methaemoglobinaemia and metabolic acidosis in infants, which resolved with fluid resuscitation, methylene blue, and dietary management using breast milk and elemental formula.", "population_specificity": "A previously healthy neonate fed with infant formula.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:15.075306+00:00"}
{"study_id": 9753, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the nutritional composition, efficacy, and tolerance of hydrolyzed rice-based formulas (HRFs) as an alternative for infants with cow's milk allergy (CMA).", "results_summary": "The study found that HRFs exhibit excellent efficacy and tolerance, providing normal growth in both healthy children and those with CMA, making them a suitable alternative for infants who cannot tolerate extensively hydrolyzed cow's milk formulas (eHF) or have severe CMA symptoms.", "population_specificity": "Infants and children with cow's milk allergy (CMA), particularly those in the first year of life.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:15.917105+00:00"}
{"study_id": 9755, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the immune response effects of oral immunotherapy (OIT) on blocking antibodies, T cell regulation, and cytokine response in children with IgE-mediated cow's milk allergy (CMA).", "results_summary": "OIT showed a 100% clinical success rate, with increased IL-10 and TGF-\u03b2 levels, elevated cow's milk-specific IgA and IgG4, and similar FoxP3 mRNA expression to natural tolerance. However, cow's milk sIgE levels decreased non-significantly, and Treg cell percentages remained unchanged.", "population_specificity": "59 children with IgE-mediated CMA (63.6% female, mean age 42.6 months) and 18 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Maintenance phase lasted at least 2 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:17.698042+00:00"}
{"study_id": 9757, "supplement_id": 1054, "safety_score": "60", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether human milk-derived fortifier (HMDF) could effectively rescue very preterm infants with intolerance to cow's milk-derived fortifier (CMDF).", "results_summary": "The study found that HMDF was well-tolerated and improved feed tolerance and growth trends in infants who were intolerant to CMDF, though thrombocytosis persisted in some cases.", "population_specificity": "Very preterm infants (gestational age \u2264 32 weeks) admitted to NICU with feed intolerance, systemic symptoms, or thrombocytosis.", "effective_dosage": "Not specified", "study_duration": "Until discharge (duration not explicitly stated)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:21.081565+00:00"}
{"study_id": 9756, "supplement_id": 1054, "safety_score": "40", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the accuracy of the Cow's Milk Related Symptom Score (CoMiSS) for diagnosing cow's milk allergy in infants and assess its relationship with dietary patterns and growth indices.", "results_summary": "The study found that 35% of infants tested positive for cow's milk allergy, with significant associations between allergy and diet (p < 0.001) as well as growth indices (weight, height, head circumference). However, common infancy issues like colic and reflux may interfere with accurate diagnosis, reducing CoMiSS reliability.", "population_specificity": "250 infants (117 boys, 133 girls) aged 2.9 \u00b1 1.6 years referred to a pediatric health center in Sulaymaniah.", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:22.420868+00:00"}
{"study_id": 9758, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of intramammary antibiotic therapy during the dry period on the udder milk microbiota in cows, comparing treated and untreated groups.", "results_summary": "The study found that antimicrobial therapy prior to dry-off influenced microbial correlations in milk at dry-off but had no significant effect on the microbiota post-partum. No bacterial taxa were significantly correlated with post-partum samples in untreated cows.", "population_specificity": "23 cows receiving intramammary antibiotic treatment and 27 untreated cows.", "effective_dosage": "Not specified", "study_duration": "From dry-off (~60 days before calving) to post-partum (4-11 days after calving).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:22.986521+00:00"}
{"study_id": 9761, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of using nasal allergen provocation testing to diagnose cow's milk allergy by assessing nasal mucosal reactivity during an oral food challenge.", "results_summary": "The study found that oral cow's milk allergen challenge induced a positive reaction in the nasal mucosa, as confirmed by optical rhinometry, tryptase levels in nasal lavage fluid, and exfoliative cytology. This suggests nasal reactivity could be a diagnostic marker for food allergies.", "population_specificity": "18-year-old girl with cow's milk allergy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:24.618751+00:00"}
{"study_id": 9759, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the palatability preferences of mothers and physicians regarding unflavored extensively hydrolyzed formulas and amino acid-based formulas for infants with cow milk protein allergy.", "results_summary": "Neocate Junior-Numil\u00ae was ranked as the top product by both mothers (63.8%) and physicians (69.8%), with mothers rating it significantly higher than physicians. No differences were found in taste, smell, or appearance ratings for Neocate Junior-Numil\u00ae between the two groups.", "population_specificity": "Mothers of infants with cow milk protein allergy and pediatricians from gastroenterology and allergy subspecialties in Turkey.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:24.678349+00:00"}
{"study_id": 9760, "supplement_id": 1054, "safety_score": "20", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the experiences and attitudes of parents of children with cow's milk allergy and other food allergies, focusing on diagnosis, treatment, and follow-up challenges.", "results_summary": "The study found that cow's milk was the most common food allergen (85.3%), diagnosis was often delayed (mean time of 10.9 months), and only 21.1% of patients adhered to hypoallergenic formula recommendations.", "population_specificity": "Parents of children with food allergies, particularly cow's milk protein allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:25.319723+00:00"}
{"study_id": 9763, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether a specific whey-based partially hydrolyzed formula (pHF) could reduce the risk of cow's milk protein allergy (CMPA) and atopic dermatitis (AD) in high-risk infants compared to a standard cow's milk-based formula (SF).", "results_summary": "The study found that the whey-based pHF significantly reduced the incidence of AD (10.6% vs. 18.7%) and showed a trend toward reducing CMPA (3.8% vs. 7%), particularly in infants with a family history of AD, where the risk reduction was 76%.", "population_specificity": "Healthy, non-exclusively breastfed full-term infants at high risk for allergy.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:27.896751+00:00"}
{"study_id": 9762, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the hypoallergenicity, growth, and gastrointestinal tolerability of a new extensively hydrolyzed whey-protein formula (eHWF) in children with cow's milk allergy (CMA).", "results_summary": "The study found that the new eHWF was well-tolerated by all subjects, meeting international hypoallergenicity criteria, and was associated with normal growth curves and transient changes in stool frequency and consistency. One child experienced a moderate allergic reaction during follow-up, indicating the need for monitoring.", "population_specificity": "34 children with confirmed cow's milk allergy (74% IgE-mediated), mean age 61 weeks.", "effective_dosage": "eHWF supplemented with prebiotic short-chain galacto- and long-chain fructo-oligosaccharides (0.8 g/L, ratio 9:1), arachidonic acid (0.35/100 g), and docosahexaenoic acid (0.35/100 g).", "study_duration": "7-day open food challenge, with an optional 16-week follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:28.286049+00:00"}
{"study_id": 9764, "supplement_id": 1054, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if an amino acid-based formula supplemented with human milk oligosaccharides supports normal growth and is well tolerated in infants with cow's milk protein allergy.", "results_summary": "The study found that the formula supported normal growth, improved gut microbiota by increasing beneficial bifidobacteria and reducing Proteobacteria, and was well tolerated with an excellent safety profile.", "population_specificity": "Term infants aged 1-8 months with moderate-to-severe cow's milk protein allergy.", "effective_dosage": "Not specified (amino acid-based formula supplemented with 2'-fucosyllactose and lacto-N-neotetraose).", "study_duration": "4 months (with optional continuation until 12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:31.128197+00:00"}
{"study_id": 9766, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of a Smart Personalised Nutrition (SPN) service in modifying gut microbiota composition and metabolic function, particularly in individuals with gluten-related disorders or cow's milk allergy/intolerance.", "results_summary": "The abstract does not provide specific results regarding cow's milk's effects, as the study is described as an ongoing randomized clinical trial.", "population_specificity": "Normal weight and overweight adults, children with obesity, and individuals with gluten-related disorders or cow's milk allergy/intolerance.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:31.553301+00:00"}
{"study_id": 9765, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to identify clinical and laboratory biomarkers of adverse events during oral immunotherapy (OIT) for children with cow's milk allergy.", "results_summary": "Adverse reactions were common during the build-up phase (73.8% of patients) but significantly reduced during the maintenance phase. Higher CM-specific IgE levels and cough during oral food challenges were associated with increased reaction risks, while younger age at OIT onset reduced risks.", "population_specificity": "86 children older than 36 months with cow's milk allergy.", "effective_dosage": "11,767 CM doses administered during the build-up phase (specific dosage not detailed).", "study_duration": "Build-up phase median 19 weeks; maintenance phase median 86.5 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:32.677178+00:00"}
{"study_id": 186065, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess iron absorption in children, preterm infants, and full-term infants, including the impact of cow's milk on iron absorption.", "results_summary": "The study found that unmodified cow's milk reduces iron absorption, while breast milk has high iron bioavailability. Supplemental iron is recommended at 4-6 months for full-term infants and sooner for preterm infants.", "population_specificity": "Children, preterm infants, and full-term infants up to 24 months of age.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Ascorbic acid increases iron absorption; lactoferrin and prebiotics may enhance absorption but require further study.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:33.683486+00:00"}
{"study_id": 186066, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine the extent to which recombinant human lactoferrin (rhLF) produced by Effera\u2122 could support immune function and iron homeostasis in adults.", "results_summary": "The abstract suggests that bovine lactoferrin supplementation supports immune function and iron homeostasis in adults, but does not provide specific results for rhLF.", "population_specificity": "Adults", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:33.780986+00:00"}
{"study_id": 9767, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to unify diagnostic and therapeutic criteria for Cow's Milk Protein Allergy (CMPA) in Latin American children through expert consensus.", "results_summary": "The study developed 28 consensus statements with over 75% expert agreement, focusing on clinical manifestations, diagnostic tools, and treatment for CMPA, but did not report specific outcomes related to Cow's Milk's effects.", "population_specificity": "Latin American children with Cow's Milk Protein Allergy (CMPA).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:33.782310+00:00"}
{"study_id": 186068, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the impact of iron deficiency and strategies for its prevention, not specifically Cow's Milk.", "results_summary": "The study did not evaluate Cow's Milk; it focused on iron deficiency, its consequences, and prevention strategies like dietary diversification, fortification, and supplementation.", "population_specificity": "Infants, children, and adolescents, particularly in low-income settings.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:35.791451+00:00"}
{"study_id": 186069, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of dietary interventions, specifically the removal of cow's milk, in managing symptoms of pediatric disorders of gut-brain interaction (DGBIs).", "results_summary": "The study found that removing cow's milk from the diet of infants with colic or regurgitation, or from the maternal diet in breastfed infants, was beneficial. However, the abstract does not provide detailed statistical or clinical outcomes for cow's milk specifically.", "population_specificity": "Infants with colic or regurgitation, and breastfed infants whose mothers consumed cow's milk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:37.252537+00:00"}
{"study_id": 186074, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to investigate the efficacy of Cow's Milk supplementation in colicky breastfed infants.", "results_summary": "The abstract does not provide specific results regarding Cow's Milk's effects, only mentioning supplementation for 28 days.", "population_specificity": "Colicky breastfed infants.", "effective_dosage": "Not available.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:40.567750+00:00"}
{"study_id": 186070, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a human breast milk-based fortifier reduces the prevalence of NEC, sepsis, and mortality in ELGA infants compared to a bovine-based fortifier.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet concluded.", "population_specificity": "Extremely low gestational age (ELGA) infants (born <gestational week 28+0) fed human breast milk.", "effective_dosage": "Not specified", "study_duration": "Until postmenstrual week 34+0", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:40.641894+00:00"}
{"study_id": 186073, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Bifidobacterium bifidum TMC3115 supplementation could reduce allergic responses and improve gut microbiota in infants with cow's milk protein allergy (CMPA).", "results_summary": "B. bifidum TMC3115 reduced allergic scores, improved anti-inflammatory responses, and altered gut microbiota composition in CMPA infants, increasing beneficial bacteria and reducing pathogens. Serum IgE levels decreased while IgG2 levels increased, suggesting a potential mechanism for allergy reduction.", "population_specificity": "256 infants diagnosed with cow's milk protein allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:42.260069+00:00"}
{"study_id": 186075, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the fate of bovine milk oligosaccharides (BMO) in the human gastrointestinal tract and assess their impact on microbial and host gene expression.", "results_summary": "The study found that BMO were fully fermented in the gastrointestinal tract with no significant changes in microbial gene expression across all participants, though minor changes were observed in four of six subjects. Host gene expression remained unaltered, and excreted BMO levels did not differ from baseline.", "population_specificity": "Healthy human adults", "effective_dosage": "Two BMO doses (specific amounts not provided)", "study_duration": "11-day periods for each dose", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:43.047127+00:00"}
{"study_id": 186072, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the preventive effects of avoiding temporary supplementation with cow's milk formula in the first few days of life on food allergy development.", "results_summary": "The study found low to moderate evidence that avoiding temporary supplementation with cow's milk formula in the first few days of life may help prevent food allergies. No significant adverse effects were reported, but the focus was primarily on prevention rather than safety or efficacy of cow's milk itself.", "population_specificity": "Infants in the first few days of life.", "effective_dosage": "Not specified", "study_duration": "First few days of life", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:43.513536+00:00"}
{"study_id": 186071, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the relationship between the timing of cow's milk formula (CMF) discontinuation and the development of cow's milk allergy (CMA) in infants who received CMF in the first 3 days of life.", "results_summary": "Early discontinuation of CMF, especially within the first month of life, was significantly associated with higher CMA incidence at 6 months compared to continuous CMF ingestion. The risk ratios were notably elevated for discontinuation before 1 month (RR 65.7), between 1-2 months (RR 18.4), and 3-5 months (RR 16.2).", "population_specificity": "Infants from a birth cohort in 4 Japanese hospitals who ingested CMF in the first 3 days of life.", "effective_dosage": "Not specified", "study_duration": "Follow-up until 6 months of age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:43.516464+00:00"}
{"study_id": 186076, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the economic and clinical outcomes of an exclusive human milk diet (EHMD) versus a diet including cow's milk-based products for very low birth weight (VLBW) babies.", "results_summary": "The study found that an EHMD significantly reduces mortality and improves health outcomes while generating substantial cost savings ($16,309 per infant from healthcare savings, increasing to $117,239 when societal costs are included) compared to diets with cow's milk-based products.", "population_specificity": "Very low birth weight (VLBW) babies (below 1250 g) in the US.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:45.230152+00:00"}
{"study_id": 186077, "supplement_id": 1054, "safety_score": "85", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to systematically review the efficacy and safety of probiotics as an adjunct in managing Cow's Milk Protein Allergy (CMPA) in infants.", "results_summary": "Probiotic supplementation was associated with a higher rate of tolerance acquisition to cow's milk protein at 36 months but did not significantly resolve hematochezia earlier. The evidence quality was low, influenced by one large study.", "population_specificity": "Infants with suspected or confirmed Cow's Milk Protein Allergy (CMPA).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Outcomes were assessed at 6, 12, 24, and 36 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:46.762906+00:00"}
{"study_id": 186079, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether hydrolysed formulas (compared to cow's milk formula or human breast milk) prevent allergic diseases in infants, including assessing different types of hydrolysed formulas and risk levels.", "results_summary": "The study found no evidence supporting hydrolysed formulas over cow's milk formula or breast milk for preventing allergic diseases, with very low-quality evidence suggesting a possible reduction in infant cow's milk allergy with short-term use of extensively hydrolysed formula.", "population_specificity": "Infants, including those at low or high risk of allergic disease.", "effective_dosage": "Not specified", "study_duration": "Varied (short-term: 3-4 days; prolonged: duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:50.048059+00:00"}
{"study_id": 186078, "supplement_id": 1054, "safety_score": "80", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether enteral supplementation with bovine lactoferrin derived from cow's milk reduces the risk of late-onset infections in very preterm infants.", "results_summary": "The study found no significant reduction in late-onset infections with bovine lactoferrin supplementation (29% in the intervention group vs. 31% in the control group), with a risk ratio of 0.95 (95% CI 0.86\u20131.04). Two serious adverse events in the lactoferrin group were possibly related to the intervention.", "population_specificity": "Very preterm infants born before 32 weeks' gestation in 37 UK hospitals, younger than 72 hours at randomization.", "effective_dosage": "150 mg/kg per day (maximum 300 mg/day), administered once daily.", "study_duration": "Until 34 weeks' postmenstrual age.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:50.851738+00:00"}
{"study_id": 186082, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the applicability of donkey's milk as an alternative for infants with Cow Milk Protein Allergy (CMPA) compared to human and other milk types.", "results_summary": "Donkey's milk showed similar chemical composition and protein homogeneity to human milk, with nutraceutical and functional properties supporting immunity, metabolism, and gut microbiota. Clinical studies indicated good tolerance (82.6%-88%) in infants with CMPA.", "population_specificity": "Infants suffering from Cow Milk Protein Allergy (CMPA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:51.798126+00:00"}
{"study_id": 186081, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine an age-related Cow's Milk-related Symptom Score (CoMiSS) in healthy infants to reduce false reassurance or over-diagnosis of cow's milk protein allergy (CMPA).", "results_summary": "The study found a median CoMiSS of 3.0 in healthy infants \u22646 months, with the 95th percentile at 9. Crying, regurgitation, and eczema scores varied significantly by age, while other components did not.", "population_specificity": "Presumed healthy infants aged \u22646 months from Belgium, Italy, Poland, and Spain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:52.212144+00:00"}
{"study_id": 186083, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the triacylglycerol (TAG) composition in infant formulas (including cow's milk-based) with mature human milk (MHM) to assess suitability for Chinese infants.", "results_summary": "Cow's milk-based formulas had higher proportions of certain TAGs (short-chain/medium-chain saturated fatty acids, OOO, ACN 54) and lower ACN 52 compared to MHM. The stereochemical structure and content of OPL and OPO differed significantly between formulas and MHM, suggesting cow's milk formulas may need additional TAGs with palmitic acid at the sn-2 position for optimal infant nutrition.", "population_specificity": "Chinese infants (implied by focus on suitability for this demographic).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:53.954148+00:00"}
{"study_id": 186084, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of a novel donkey milk-based fortifier versus a traditional cow's milk-based fortifier on feeding tolerance, growth, and clinical outcomes in preterm infants.", "results_summary": "The abstract does not provide specific results regarding cow's milk effects, as the study focuses on comparing donkey milk and cow's milk-based fortifiers without detailing outcomes for cow's milk alone.", "population_specificity": "Preterm infants born <1500 g and <32 weeks of gestational age.", "effective_dosage": "Not specified (fortification protocol was isoproteic and isocaloric for both groups).", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:54.408854+00:00"}
{"study_id": 186087, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether hydrolysed formulas (compared to cow's milk formula or human breast milk) could prevent allergies in infants, and which types of hydrolysed formulas or feeding durations were most effective.", "results_summary": "Prolonged hydrolysed formula feeding reduced infant allergy and cow's milk allergy compared to cow's milk formula, but no difference was found in childhood allergy or specific allergies like asthma, eczema, or rhinitis. Short-term hydrolysed formula use showed no significant benefits over human milk or cow's milk formula.", "population_specificity": "Infants, including those at high or low risk of allergy.", "effective_dosage": "Not specified (varies by study, including short-term supplementation and prolonged feeding).", "study_duration": "Ranged from 3-4 days (short-term) to prolonged feeding periods (unspecified exact duration).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:57.853820+00:00"}
{"study_id": 186088, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of hydrolysed formulas versus cow's milk formula (CMF) or human breast milk on allergy and food allergy prevention in infants, and to determine which types of hydrolysed formulas are most effective.", "results_summary": "Prolonged feeding with hydrolysed formulas reduced infant allergy and cow's milk allergy (CMA) compared to CMF, but no difference was found in childhood allergy or specific allergies like asthma, eczema, or rhinitis. Short-term use of extensively hydrolysed formula (EHF) showed borderline reduction in infant CMA, but evidence quality was very low.", "population_specificity": "Infants, including those at high or low risk of allergy.", "effective_dosage": "Not specified", "study_duration": "Varied (short-term: 3-4 days; prolonged: duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:00.308100+00:00"}
{"study_id": 186089, "supplement_id": 1054, "safety_score": "60", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the prevalence of iron deficiency in European children aged 6-36 months, particularly focusing on the impact of cow's milk consumption as a main drink in the first year of life.", "results_summary": "The study found that cow's milk consumption as a main drink in the first year of life was associated with a higher prevalence of iron deficiency in infants aged 6-12 months. Prevalence rates of iron deficiency varied widely, with higher rates in socially vulnerable children and those in Eastern Europe.", "population_specificity": "European children aged 6-36 months, with specific focus on infants (6-12 months) and young children (12-36 months).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:01.057399+00:00"}
{"study_id": 186080, "supplement_id": 1054, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of cow's milk as a primary beverage for toddlers and its impact on nutritional habits and overall health.", "results_summary": "The study found that cow's milk is recommended as a primary beverage for toddlers aged one to two years, alongside breast milk, to support healthy growth and development. It also emphasized avoiding sugar-sweetened beverages and promoting water or milk instead.", "population_specificity": "Toddlers aged one to two years.", "effective_dosage": "Not specified (recommended as primary beverage).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:01.493297+00:00"}
{"study_id": 186091, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 20, "quality_score": 50, "study_goal": "The researchers aimed to investigate the role of cow's milk in the development of anemia in infants, particularly its association with inadequate nutrition and iron deficiency.", "results_summary": "The study found that infants supplemented with cow's milk had a higher incidence of anemia, with severe anemia more common in those breastfed for shorter durations. The highest percentage of anemic children in both studies were fed cow's milk as a supplement.", "population_specificity": "Infants aged 1-24 months (first study) and 1-12 months (second study) with varying degrees of anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:01.546565+00:00"}
{"study_id": 186092, "supplement_id": 1054, "safety_score": "30", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to assess the relationship between whey protein supplementation (derived from cow's milk) and the onset or exacerbation of acne vulgaris in young adults.", "results_summary": "The study found a statistically significant association (p < 0.0005) between whey protein supplementation and the onset or worsening of acneiform lesions, particularly in females and individuals without current acne or a family history of acne. The effect was observed progressively over a two-month period.", "population_specificity": "Young adults (30 participants) in gyms and a dermatology clinic in Jo\u00e3o Pessoa, Brazil.", "effective_dosage": "Not specified", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:03.036058+00:00"}
{"study_id": 186090, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the rehydration potential of cow's milk with other beverages (soy milk, a milk-based supplement, and a sports drink) after exercise-induced fluid loss.", "results_summary": "Cow's milk was more effective than the sports drink (Powerade) in retaining fluid post-exercise, with 40.0% beverage retention, but less effective than the milk-based supplement (Sustagen Sport). Subjective ratings indicated higher bloating and fullness with milk-based drinks compared to Powerade, but no difference in overall thirst.", "population_specificity": "15 male participants (age 24.9 \u00b1 5.5 years, height 179.3 \u00b1 4.9 cm, body mass 75.8 \u00b1 6.6 kg).", "effective_dosage": "Volume equivalent to 150% of body mass loss, consumed over 1 hour.", "study_duration": "4-hour post-consumption monitoring.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:03.243317+00:00"}
{"study_id": 186093, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not directly assess cow's milk but compares its characteristics and effects to donkey's and goat's milk.", "results_summary": "The study does not report specific findings about cow's milk but highlights that donkey's and goat's milk may be better alternatives for individuals with cow's milk intolerance or inflammatory/allergic conditions.", "population_specificity": "Infants with cow's milk intolerance and individuals with inflammatory/allergic conditions, including elderly people.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:03.586968+00:00"}
{"study_id": 186095, "supplement_id": 1054, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of cow's milk in iron deficiency and provide dietary recommendations for infants and toddlers.", "results_summary": "The study found that high cow's-milk intake is a risk factor for iron deficiency anemia (IDA) in young children. Unmodified cow's milk should not be the main milk drink for infants under 12 months, and intake should be limited to <500 mL/day in toddlers.", "population_specificity": "Infants and toddlers, including those with moderately or marginally low birth weight, and high-risk groups such as socioeconomically disadvantaged and immigrant families.", "effective_dosage": "Not specified (only intake limits provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:09.658413+00:00"}
{"study_id": 186098, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether dietary interventions, including cow's milk-free formulas, could prevent or delay the onset of type 1 diabetes in infants with high genetic risk.", "results_summary": "The abstract mentions that cow's milk-free formulas were tested as a primary prevention strategy, but it does not provide specific results regarding their effectiveness in altering the disease course. Other dietary manipulations were also explored, but no conclusive findings about cow's milk's role are detailed.", "population_specificity": "Infants with high genetic risk for type 1 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:10.380085+00:00"}
{"study_id": 186097, "supplement_id": 1054, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the relationship between cow's milk intake and serum 25-hydroxyvitamin D levels in children, particularly comparing non-Western immigrant families to Western-born families.", "results_summary": "Higher cow's milk intake was associated with increased serum 25(OH)D levels (P < 0.0001), suggesting a positive effect on vitamin D status. The study found that cow's milk intake was one of the statistically significant covariates influencing vitamin D levels, alongside supplementation and seasonal factors.", "population_specificity": "Healthy children aged 1-6 years from both non-Western immigrant and Western-born families in Toronto, Canada.", "effective_dosage": "Mean cow's milk intake was 1.8 cups per day.", "study_duration": "Not specified (cross-sectional study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:11.241927+00:00"}
{"study_id": 186096, "supplement_id": 1054, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether vitamin D-fortified growing up milk could prevent the seasonal decline in serum 25-hydroxyvitamin D concentrations in young children compared to regular semi-skimmed cow's milk.", "results_summary": "The study found that daily consumption of vitamin D-fortified growing up milk prevented the typical winter decline in serum 25-hydroxyvitamin D levels, while no adverse effects were observed during summer. The fortified milk was more effective than unfortified cow's milk in maintaining adequate vitamin D status.", "population_specificity": "Young children aged 2-6 years (n=92).", "effective_dosage": "2.85 \u03bcg/100 ml of vitamin D-fortified growing up milk.", "study_duration": "The intervention lasted through winter and summer seasons (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:11.862578+00:00"}
